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In the last few years a very high incidence of deep vein thrombosis 
has been reported in the literature (1 - 8). Venous thrombosis 
and its sequel, pulmonary embolus account for 12. 5% of all 
postoperative deaths and is the single greatest threat to 
recovery after surgical operations (9). Thi s study was undertaken 
to investigate the incidence of postoperative deep vein thrombosis 
occurring at Groote Schuur Hospital using the newer method~ 
of diagnosis. 
South Africa. 
No previous similar study has been conducted in 
The high risk factors predisposing to venous 
thrombosis have been assessed and the techniques of diagnosis 
using Radio-active fibrinogen, Doppler ultrasound and Venography 
have been studied. 
The local findings reported in this study confirmed the high 
reported incidence. Methods of prevention of venous 
thrombosis using low does heparin and sodium pentosan 
polysulphate have been assessed. 
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2. REVIEW OF THE LITERATURE 
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Deep v ein thrombosis is a common complication o f surgical 
ope rations and its sequel pulmonary embolism, is responsible 
for considerable morbidity and mortality postoperatively. 
1. CLINICAL DIAGNOSIS 
It is well recognised that many small calf vein thromboses 
give rise to no symptoms or signs (7). More importantly 
extensive femoral or iliac vein thrombosis may silently exist, 
unless sho.wn by special investigation or by the presentation of 
pulmonary emboli (10, 11). 
Not only is deep vein thrombosis often overlooked, it is also 
frequently diagnosed when none is present ( 10). As many as 
two thirds of patients showing deep vein thrombosis are not 
suspected on clinical grounds despite careful examination. 
Furthermore, in patients in whom the clinical diagnosis of 
v e nous thrombosis had been made, the diagnosis might be falsely 
positive in 25 to SO% of cases (7). The most important symptom 
is a feeling of heaviness or continuous dull pain in the calf. 
This sensation is aggravated by muscular contraction or the 
erect posture. The signs of unilateral ankle oedema, increased 
girth around the calf, tenderness of the calf , pre-tibial venous 
dilatation and increase in the tension of the calf muscles are the 
classic al clinical diagnostic features of venous thrombosis ( 12, 13). 
The rare presentation of ilia -femoral venous thrombosis in the 
severest form is a phlegmasia caerulea dolens after a sudden 
onset of acute pain, is characteristic. There is a diffuse 
oedema of the whole of the lower limb including the thigh, calf 
and ankle with associated tenderness ( 14}. 
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Temperature chart analysis can detect half of those patients 
developing clots in the legs. · If the patient is afebrile, any 
venous thrombosis present is more likely to be of a short 
duration and therefore less likely to extend into the more 
proximal vessels (15). 
2. RADIO-ACTIVE 1
125 
LABELLED FIBRINOGEN TECHNIQUE 
This technique was first described in 1960 by Hobbs and Davies (16), 
and their work was followed by the studies of Atkins and Hawkins 
and of Nanson in 1965 (17, 18). The accuracy of the technique 
used in a prospective manner was finally established in 1968 by 
comparison with phlebography by Flanc et al (19), at King's 
College Hospital and by Negus at The Middlesex Hospital (8). 
The technique depends on the fact that human Fibrinogen, 
labelled with a suitable isotope, is, incorporated into the forming 
thrombi and a concentration of the isotope can be detected by a 
. bl 1 I d . - l 2 5 . . d · f su1ta e externa counter. o 1ne 1s use 1n pre erence to 
-131 
Isotope I , because of its longer half life (60 days as compared 
to 8 days) which facilitates storage and also ensures an adequate 
blood concentration during the 7 or 8 day period of monitoring. 
Measurement of radio-activity is made with a scaler using a 
collimated scintillation counter designed to measure a field of 10 ems 
diameter and 3. 75 ems depth. A single channel pulse height 
analyser is used, the lower level corresponding to 5 kev. and the 
upper to 50 kev. More recently a small portable ratemeter 
called the Isotope Localisation Monitor 235 , D. A. Pitman Ltd. 
(Fig. 1) has been introduced at a relatively inexpensive price. 
The Pitman Ratemeter, which is portable, appears to be as 
accurate as a scaler except at very low count rates which may 
occur five to six days after injection of labelled fibrinogen. 
FIGURE 1. RATEMETER (PITMAN MODEL 235 




T e chnique of Patient examination 
The thyroid uptake of radioactive iodine is blocked by administration 
of 150 mg. potassium iodide which is given orally 24 hours before 
the injection of the isotope-labelled Fibrinogen and is continued 
d aily for the following two weeks. One hundred microcuries of 
I 
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Human Fibrinogen, obtained from a small pool of hepatitis-
free donors, is then injected intravenously and counts of radio-
activity are made at selected points on the lower limb and the 
activity of each is recorded. All measurements are made in the 
ward with the patient lying supine in bed, and the legs elevated 
0 
10 above the horizontal in order to avoid venous pooling. 
The points of measurement on the legs are indicated in figure 2 ii and b. 
The distance between these points depends on the size of the 
collimator used. With the scaler counts are made at 10 ems 
intervals. If a smaller collimator is used such as the Pitman 
Ratemeter, it is necessary to perform counts at 5 ems intervals. 
Daily counts are made over the precordial area as well as over points 
on the limb, and activity at each point on the limb is expressed as 
a percentage of the heart count measured on the same OGcasion. 
This method eliminates the need for calculating biological or 
radioactive decay. With the Pitman Ratemeter, the radio-
activity at each point on the leg can be expressed as a percentage 
of the heart count by simple use of a control that adjusts the 
precordial counts to a figure of 100% (Fig. 3). This obviates 
calculation and greatly simplifies measurement. The count at 
any one point on the limb, expressed as a percentage of the heart 
rate, measured on the same occasion, is compared with the 
count at the same point on the previous day and is also compared 
with adjacent poiri:s on the same limb and with the corresponding 
point on the opposite limb. Comparison with phlebography 
by Negus (8) has shown that a rise of 15% in the ca.mt rate 
using the scaler (28), and 2.0% using the Pitman Ratemeter, 
9 
indicates the presenc e of venous thrombosis, 
provided that the 
rise in the activity persists and increases on 
the succeeding day. 
The figure of 15% applies to the detection of 
calf thrombosis.' 
The baseline counts in the thigh are higher an
d a proportionally 
greater increase in percentage activity is req
uired for diagnosis. 
Advantages 
This technique has the advantage that it is a s
imple one, causes 
no discomfort to the patient, and is suitable f
or repeated monitoring. 
It is therefore particularly useful in prospect
ive studies of the 
natural history of postoperative venous throm
bosis {8, 19). 
The I-
125 fibrinogen technique can also be applied to re
search 
into methods of prevention of deep vein throm
bosis. It has been 
used by a number of workers as an objective 
method of diagnosis 
in controlled trials of preventing deep vein t
hrombosis {6,20,21,22,23) 
as well as evaluating methods of treating veno
us thrombosis {24). 
It is furthermore a reliable screening method
 for detecting thrombi 
m the lower leg and thigh {10). 
In the diagnosis of the early suspected case, 
the technique is 
between 80% and 92% accurate (25, 26), but c
are should be used 
in interpreting the result if the patient has had
 symptoms or signs 
suggestive of deep vein thrombosis for more 
than 5 days. 
In the diagnosis of the suspected case, it take
s 6 hours for the 
radioactive fibrinogen to be concentrated suff
iciently for 
detection with a scintillation counter, and a de
finite diagnosis 
is not possible for 24 hours {10, 28). 
Limitations 
i. This technique is useless for the diagnosis
 of thrombi in the 
upper femoral or iliac vessels, and is only re
liable up to 10 ems 
of the inguinal ligament {10, 28). 
1 0 
ii. It is unreliable in the presence of healing wounds because these 
take up fibrinogen, and it cannot therefore be used after operations 
to the lower limbs (10). 
111. It is not quite as accurate in the diagnosis of established 
thrombi (10, 25, 26). 
iv. It is inaccurate if gross oedema is present, such as in 
congestive cardiac failure because the fibrinogen diffuses out ( 10). 
v. Pregnancy is a contraindication. 
vi. It is expensive, time consuming and requires a trained 
technician(2 7). 
vii. Is a possible risk of serum hepatitis but no cases seen in 
800 patients studied by Kakkar (26). 
- 125 
In summary the use of I fibrinogen is a simple, accurate, 
portable, non-invasive method of detecting deep vein thrombosis 
in the patient postoperatively. 
FIGURE 2A POSITIONS AT WHICH RADIOACTIVITY 
IS MEASURED 
__, .._..,,. 
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FIGURE 2B POSITIONS AT WHICH RADIOACTIVITY 
. IS MEASURED 




FIGURE 3. PRINCIPLE OF RATEMETER. 
READINGS ON LINEAR SCALE ARE 
DIRECT PERCENTAGE OF HEART COUNT 
0 0 0 0 
- 0 0 0 0 
\ 0 0 0 0 
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3. DOPPLER ULTRASOUND TECHNIQUE 
The use of ultrasound for the diagnosis of venous thrombosis was 
first described by Strandness in 1967 (29) and Sigel in 1968 extended 
this application, using a machine operating at 5 mega Hertz (30, 31). 
Both teams were able to directly determine the presence of deep 
venous flow from calf to groin. The technique was further modified 
by Evans and Cockett in 1969 wp.o changed the transmission 
frequency to 2 mega Hertz (32). This increases tissue 
penetration and allows direct examination of the iliac veins and 
inferior vena cava. The machine used is a Sonicaid D205M 
(fig. 4) Sonicaid Limited, Sussex, which has the advantage of 
simplicity of operation, is portable, inexpensive, and totally 
safe to the patient. The machine consists of a transmitter 
operated at 2 tnHz, a receiver, an · audioamplifier, and a 
loudspeaker contained in a case approximately 30 x 20 x 7. 5 ems 
and weighing 3 kg. which can easily be carried from bed to bed. 
A transducer containing 2 ceramic crystals, one of which emits 
ultrasound and the other acting as a receiver, is connected to the 
cabinet by a detachable lead. Usually the examiner listens for 
a "whoo sing" sound, although if desired, permanent recording 
called a Dopplergram can be obtained by connecting a lead from 
a pen-recorder to the transmitter, or alternatively the examiner 
can listen through a set of head phones. 
When a stationary column of blood is examined, the reflected 
signal is identical to the transmitted and no sound is heard from 
the loudspeaker. However, when moving blood is examined, 
there is a shift in the frequency of the reflected signal proportional 
to the velocity of flow, due to the Doppler effect. This shift in 
frequency is within the audible range and with suitable amplifications 
can be heard. The presence of moving blood is therefore indicated 
by a sound, while in venous obstruction there is silence. 
1 8 
Sigel (30, 31) showed that if a squeeze was applied to the leg distal 
to the site of the transducer, an augmentation of venous flow 
velocity would occur and a roar or "whoosh" would be heard 
from the loudspeaker. This he termed the Augmentation 
wave or A wave. An A wave indicates the presence of deep 
venous flow between the site of squeezing and the transducer. 
Technique of patient examination 
Patient examined in bed in the ward, sitting propped up and 
flexed with the hips at 45° or more. The lower limbs are 
straight and the ankles supported to allow good passive filling 
of the calf veins ( 10, 33). The transducer is applied to the 
skin overlying the vein to be .examined, using a suitable 
coupling medium such as olive oil. The transducer is sited 
over femoral vein 10 cm. below the inguinal ligament, 
the common femoral vein, the external iliac vein, and over 
the inferior vena cava ( 33) and popliteal vein ( 34). 
To produce "A-waves" the leg is squeezed by hand over the 
upper thigh along the line of the superficial vein, over the mid 
thigh, over the lower thigh at the level of the adductor canal 
and calf. In patients with painful calves, the squeeze is 
applied using a calf pressure unit (10). This has enabled 
more accurate examinations, less discomfort to the patient, 
and elimination of occasional false positive results achieved 
on hand squeezing. Permanent visual recording of the sounds 
heard may be made by attaching the lead of a pen-recorder to 
the back of a Sonicaid D205M cabinet. 
The femoral artery is first located with the transducer by the 
characteristic pulsatile sound of major arterial flow, and the 
transducer is moved medially over the femoral vein. 
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The calf is squeezed, until the venous flow is detected by the 
presence of a roar. This is the so -called Augmentation or 
"A-wave", described by Sigel ( 30, 31). Similar observations 
can be made with the transducer over the inferior vena cava, 
the iliac veins, the femoral vein or the popliteal vein, thus 
localising the site of any obstruction. Obstruction is indicated 
by the absence of a sound, although with practice one could 
recognise a diminished sound compared with the other leg or 
with what is recognised as normal{lO, 34, 35, 36). For the 
purposes of this study however, thrombosis was only diagnosed 
by the absence of a sound. Patency of the inferior vena cava 
and iliac veins can be assessed by applying the Doppler probe 
over the common femoral vein during hyperventilation. 
Absence of obstruction is indicated by a wave-like roar 
corresponding to the respiratory excursions (30, 31). 
Advantages 
Patient examination with ultrasound is very rapid, it is possible 
to examine a patient fully in two to three minutes. This means 
that all the patients in the ward of 30 beds can be screened in 
just over an hour. Ultrasound will detect thrombus in the 
popliteal or more proximal veins, that is an anatomical region 
where deep vein thrombosis is a potential hazard to the life 
of the patient and is a useful screening method (38). 
Should there be any doubt in interpretation, the simplicity of 
testing allows repeated examination with minimum inconvenience. 
Evans ( 10, 33) suggested patients screening twice weekly as 
being feasible and sufficiently reliable for regular use. 
Ultrasound examination had proved particularly useful in 
20 
assessing collapsed patients, when massive pulm
onary embolism 
is a possible cause (10). In a small series, evid
ence of venous 
obstruction has been found in one or both legs of a
ll patients 
sustaining a massive pulmonary embolus.( 10). 
Following 
thrombectomy, ultrasound can be used to monitor
 the patency 
of veins and detect reocclusion. In pregnancy th
e deep venous 
system can be assessed without hazard to the foet
us. 
Ultrasound assessment is also indicated after low
er limb surgery, 
and in oedematous limbs when other forms of inve
stigations may 
be difficult to perform or interpret {10, 33, 37). 
Limitations 
Ultrasound examination will not detect minor calf 
vein 
thrombosis. However, if a thrombus propagates
 to the 
popliteal veins it will be detected (10, 36). If a m
ajor vein 
is only partially occluded the thrombus may be ov
er looked. 
Again, if there is a good collateral flow through a
 venous 
obstruction, thrombosis may be overlooked witho
ut careful 
siting of the transducer as already described (10, 
34, 35). 
In summary the Doppler ultrasound is a simple, p
ortable, 
quick, non-invasive method of detecting deep vein
 thrombosis 
in the patient postoperatively. 












Venography of the lower extremities was first reported
 by 
Berberich and Hirsch in 1923 (39). During the 1930's 
lower leg phlebography was introduced as a routine clin
ical 
method ( 40, 41, 42, 43). The procedure, however, lost
 its 
popularity, mainly due to technical inadequacy which ga
ve rise 
to diagnostic pitfalls (44, 45). Many improvements in
 the 
technique of venography have been described (41, 44, 46,
 47), 
and as knowledge of the dynamics of flow of venous bloo
d and 
of contrast material has increased, the reliability of th
e technique 
has improved (40). Venography is being increasingly
 used to 
confirm or exclude suspected deep vein thrombosis and
 to plan 
treatment to prevent pulmonary embolism ( 48-54). 
Radiologists and clinicians often feel that the examinat
ion is 
technically difficult to perform and interpret and that it
 is 
time-consuming, unpleasant and dangerous for the patie
nt. 
However, experience of over 600 examinations by Lea 
Thomas 
(50) suggests that phlebography can usually be rapidly c
arried 
out, causing little or no discomfort to the patient, is fr
ee of 
significant complications, and requires only standard r
adiographic 
equipment. With a little experience a thrombus can b
e recognised 
or excluded with certainty. Furthermore, phlebograph
y provides 
information not only about the presence of a thrombus, 
but also 
its exact position, size and whether it is loose or adheren
t to 
the vein wall. Loose thrombus may be shown to be lo
cked in 
by more proximal adherent thrombus, and unable to em
bolise. 
This information is unobtainable by any other diagnostic
 method (50). 
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Technique 
A tilting screen table equipped with an undercouch tube, television 
and an automatic exposure device, is most convenient. A useful 
film format is a 35 cm x 35 cm. film, which may be divided into 
three parts. Each leg is examined separately. The patient
 
lies supine on the table and a self-fastening rubber tourniquet 
is applied around the ankle to distend the foot veins. 
A No. 20 gauge 25 mm. disposable needle is bent at its hub so 
it lies flat against the dorsum of the foot. It is introduced 
percutaneously into a vein towards the more lateral side of the 
foot, in order to avoid too direct communication with a long 
saphenous system. The needle is directed towards the toes, 
that is, in an upstream direction. A second tourniquet is 
applied above the knee to trap the contrast medium in the calf 
veins. 
The table is tilted 20° downwards and the leg internally rotated 
to separate the images of the tibia and fibula. A syringe 
containing 50 ml of the contrast medium, Meglumine Iothalamate 
60% , is connected to the needle by polyethylene tube and a hand 
injection is b egun under television control. The ankle and 
above-knee tourniquets are tightened and the table tilt increased 
until deep venous filling is noted on television. It is not part 
of this technique to occlude totally the superficial venous system 
as thrombus can arise from the superficial veins (55), and also 
contrast from the long saphenous vein allows filling above an 
obstructed portion of the femoral vein . Upstream injection 
helps to fill the deep veins as the contrast medium passes 
through the communicating veins in the foot directly into the 
deep venous system (56). Two exposures are made, one 
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below the knee and one including the knee in the po
 stero -anterior 
projection. Filming is started about half-wa
y through the 
injection and judged by television screening. A
 third exposure 
is made with the legs externally rotated so that th
e lateral 
aspect of the calf lies flat on the table top. 
In this lateral 
projection the calf muscle sinusoids are not obscu
red by tibia 
and fibula. The leg is then again internally rotate
d and the 
upper tourniquet removed. Further exposur
es are made from 
the popliteal vein to the inferior vena cava. 
The patient is 
asked to perform a Valsal va man.oeuvre and the co
mmon 
femoral vein is filled with contrast in order to sho
w the 
profunda vein as far as a competent valve. Good
 filling of the 
upper femoral and iliac vein is obtained by the inj
ector applying 
firm pres sure in an upward direction to the calf w
hile the 
exposure is being made. This procedure may also
 outline 
the lower part of the inferior vena cava. 
For adequate demonstration of the iliac veins and 
lower inferior 
vena cava, a modification can be employed withou
t the use of 
ankle tourniquet, and with firm upward pressure b
eing applied 
to calves on both sides after bilateral 50 ml inject
ion of contra.st 
medium given simultaneously. A valsalva manoeuvre ma
y 




This is indicated if there is obstruction to the pro
ximal part 
I 
of the deep venous system and the full extent of t
he thrombus 
has not been adequately demonstrated. The examination 
is 
painful and therefore requires a general anaesthet
ic. 
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Often a combine d t e chnique with a percutaneous f emoral injec
tion 
of contrast medium on the non-obstructed side and a pertrocha
nteric 
injection on the other side is used. Bilateral injections are 
always required to show the inferior vena cava adequately. 
Separate iliac phlebography and inferior vena cavography is 
only required in about 5% of the patients, as these veins ar
e 
sufficiently well shown by foot injections in the remainder. 
A standard bilateral examination demonstrating the whole 
venous system from the ankle to th e inferior vena cava requir
es 
200 ml of contrast medium, but double this amount may be 
required occasionally if doubtful areas have to be re-examined
. 
Complications 
Contrast medium is known to damage the intima and predispos
e 
to thrombosis (50), but this can be avoided by thoroughly 
clearing the veins with normal saline a t the end of the 
examination. In an obstructed venous system, contrast 
medium may be trapped in the foot causing tissue damage (52)
. 
Careful aseptic precautions are necessary to prevent local 
sepsis and with intraosseous phl ebography there is always a 
danger of osteomyelitis. The use of the Valsalva manoeuvre 
has been criticised as predisposing to pulmonary embolism (5
7) 
but Lea Thomas has not encountered this complication (50). 
The use of calf pressure is also open to criticism as this may
 
dislodge fresh thrombus. The pressure used is probably 
no more than that produced by the patient involuntary contract
ing 
the calf muscles, and it is used clinically to assess calf 




The contrast medium, Meglumine Iothalamate 60%, is painles
s on 
injection and produces little discomfort to the patient apart fro
m 
a bursting sensation in an obstructed venous system. The 
relatively large quantity of contrast medium which may be 
necessary in some patients has not resulted in any complicatio
n (50). 
Interpretation of Venograms 
Unequivocal de e p vein thrombosis shows as well-defined filling
 
defects in an opacified vein which presents a constant appeara
nce 
both on screening and serial films. Loose thrombus 
appears 
as a cylindrical or rounded translucent defect separated from 
the vein wall by thin white line of contrast medium. 
Obliteration of this white line indicates adherence or fixity 
of the thrombus to the vein wall. When a thrombus obstruc
ts 
a vein or segment of the vein completely, no contrast medium
 
surrounds it, but the veins above and below and the collaterals
 
are filled with contrast. The full extent of the thrombus mus
t 
be shown in all instances and this may be at different sites in 
t .he same leg. As a thrombus ages it retracts, develops a 
thicker rim of c ontrast around it, and its surface is more 
clearly defined. A vein may remain permanently occluded 
and be bypassed by collaterals or the thrombus may organize 
leaving an irregular, often reduplicated lumen and destroyed 
valves. Study carried out by Lea Thomas and McAllister (51), 
suggested that the usual sequence of events following thrombos
is 
was for the thrombus to remain free for the first week and ov
er 
the next fourteen days to become adherent to the vein wall and
 
then contract. An obstructed vein may recanalize after 
several months or it may remain permanently occluded. 
Recanalization more frequently occurs in the calf veins than th
e 
ilio -femoral veins ( 50). 
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Appearances that may be confused with thrombus 
Most filling defects are due to normal structures such as the 
valves and artifacts . which may result from underfilling, dilution 
and streamlining of contrast which can be excluded by the screening 
technique (50). 
Limitations and value of venography 
The main disadvantage is the need for skilled medical personnel, 
possible difficulty of venepuncture and is time consuming with a 
definite though small morbidity ( 40, 50}. 
The practical advantage of venography over the use of ultrasound 
and radioactive fibrinogen is that it not only demonstrates the 
presence of a thrombus, but also shows its exact site, extent 
and degree of fixity. A thrombus shown to be loose represents 
a potential hazard from embolization. 
The choice between surgical or medical treatment may be 
assisted, for if the thrombus is loose, it should probably be 
removed surgically. If adherent , surgical removal may be 
impossible or par t ially successful with intimal damage and 
rethrombosis (48, 49, 58). 
In summary, venography gives diagnostic confirmation of 
the presence of venous thrombosis from the ankles to the 
inferior vena cava. 
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5. IMPEDANCE PHLEBOGRAPHY 
Measurement of electrical impedance (59) depends upon the 
fact that when a constant electrical current flows through part 
of the body,changes in local blood volume alter the electrical 
impedance. Measurement of the voltage thus gives an indirect 
assessment of changes in local lliod volume. 
Normally the venous blood volume in the leg varies slightly 
with venous pressure changes due to r e spiration. When 
venous thrombosis is present, the respi ratory venous volume 
changes are diminished and can be detected by impedance 
measurements. 
Technique 
The testing procedure is simple, but technical detail is 
important. A C.Odman 1 PG-100 Impe dance Phlebograph by 
Cadman and Shurtleff (59) and a Minnesota Impedance 
Cardiograph, Model 303 ( 61) are available for recording the 
measurements. Circumferential electrodes are placed at 
fixed points on the lower limb and baseline recordings are 
made with subject breathing quietly and then during deep 
inspiration, holding his breath for at least 5 seconds and then 
breathing passively. 
The most useful measurement on the tracing is the height of 
impedance change associated with deep inspiration which is 





Impedance phlebography would appear to be a useful non-invasive, 
simple screening technique, but should be checked by venography 
in almost all cases until its accuracy is improved (63). 
Limitations 
It cannot be carried out in patients unable to lie quietly, cooperate 
or hold their breath for five seconds. 
The accuracy for detection of a recent thrombosis is from 53% (61) 
to 68% (63) although Mullick (59) initially reported better results. 
It is incapable of detecting minor calf thrombosis and will probably 
not detect partial venous occlusion in the early stages of thrombosis 
or total venous occlusion in presence of adequate collaterals ( 10, 62). 
In summary, impedance phlebography appears to have similar 
limitations as the Doppler ultrasound and is not as reliable due 
to difficulty with interpretation of results. 
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6. THERMOGRAPHY 
The use of infrared photography , to detec t "hot spots" which can 
be produced by thrombophlebitis ( 64) has been suggested in the 
diagnosis of deep vein thrombosis. As yet there has been no 
systematic study of its usefulness and no comparison of its 
accuracy with venography. 
7. BLOOD TESTS 
A number of blood tests have been considered as aids to 
detecting venous thrombosis. 
a. Platelet Adhesiveness 
It was suggested that a rise in platelet adhesiveness accompanies 
deep vein thrombosis and may appear before physical signs 
become apparent ( 65, 66). This phenomenon was not confirmed 
by Negus (67). 
b. Fibrin Degradation Products and Other Tests 
Ruckley et al ( 68) found that serum fibrin degradation products 
were not helpful in detecting deep vein thrombosis but Fletcher 
found a correlation in the high risk group (71). 
Fibrinogen-fibrin related antigen was found significantly 
elevated in patients with postoperative deep vein thrombosis 
but the highest levels were recorded in those with associated 
systemic complications ( 69). 
Mansfield (70) found an earlier and more severe reduction in the 




It appears, that the changes observed in the plasma fibrinogen, 
blood lysis time, serum F. D. P, platelet count and platelet 
adhesiveness, taken alone or together, fail to discriminate 
between the patients with deep vein thrombosis and those without. 
The changes are probably a sequel to a major surgical operation 
and the 'hypercoagulable state' is probably the result rather than 
the cause of the high incidence of postoperative venous thrombosis (72). 
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II. INCIDENCE OF DEEP VEIN THROMBOSIS 
1. Introduction 
2. Magnitude of Problem 
- death certificates 
- hospital sampling 
- hospital statistics 
3. Frequency 
1. Clinical Incidence 
2. Post Mortem 
- Deep vein thrombosis 
- Pulmonary embolism 
- Increasing? 








Deep vein thrombosis and its sequel pulmonary embolus are'how 
perhaps the single greatest threat to recovery after surgical 
operations." (9) 
Thrombo -embolic disease kills 5, 000 people in Britain annually 
{73) and contributes to 12. 5% of all postoperative deaths (4). 
It is therefore a serious cause for concern. 
The problem should be considered as (i) the early mortality 
and morbidity and (ii) late mortality and morbidity. 
2. Magnitude of the Problem 
- death certificates 
- hospital sampling 
- hospital statistics 
The importance of deep vein thrombosis and pulmonary embolism 
has to be judged by their incidence and the effect on the morbidity, 
mortality and prognosis of patients undergoing surgical operations. 
Pulmonary embolism has been described as "the most acute 
pulmonary illness encountered in a general hospital, as one o'f 
the commonest lethal processes seen at necropsy and the third 
commonest non lethal afflict-ion after pneumonia and chronic 
emphysema." (74). 
The reported incidence of deep vein thrombosis and pulmonary 
embolism varies considerably but the figures must be considered 
in relation to their source and potential accuracy. Published 




For England and Wales in 1967, the Registrar-General's figures 
were 2,426 for 1 1pulmonary embolism and infarction", and 2555 
for "other venous embolism and thrombosis. 11 (75) 
From the Registrar General's figures making appropriate 
corrections, pulmonary embolism mentioned as a cause 
of death in about 21,000 death certificates in England and Wales 
during 1967 (76). 
Another approach to determine the prevalence of thrombo-
embolism is based on hospital s a mpling. Number of inpatients 
with various underlying diagnosis in hospitals in England and 
Wales were investigated by the Hospital Inpatient Enquiry. 
In 1963 the number with either pulmonary embolism and 
infarction or with other "venous embolism and thrombosis" 
was assessed as 12,502 (77), but this is much too low for 
reasons similar to those which apply to the published analysis 
of death certificates (76). 
From hospital statistics in the United States a reasonable 
estimate of the number of diagnosed cases of pulmonary 
embolism and venous thrombosis seems possible. 
Data from reports issued by the Commission on Professional 
and Hospital Activities {PAS) shows that among 5. 05 million 
patients discharged from their participating hospitals in 1966 
{all short term hospitals), there were 19, 054 patients in 
whom the diagnosis was listed either as pulmonary 
embolism and infarction or other venous embolism and 
thrombosis; 28, 799 patients with a d iagnosis of phlebitis 
and thrombo -phlebitis of the lower extreme ties. 
In 1966 "short-term" cases admitted to United States hospitals 
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totalled 28. 5 million, and assuming that the frequencies of the 
diagnosis of thrombosis and embolism were the same as in the PAS 
participating hospitals, the following figures can be calculated. 
For 1966, the total cases of pulmonary embolism in US hospitals 
was about 106,000 and the total cases of phlebitis and thrombo-
phlebitis was about 182, 000. In round figures thus there were 
approximately one quarter of a million patients with diagnosed 
venous thrombosis or embolism in US hospitals in 1966. 
These estimates exclude: patients in nursing homes or custodial 
care institutions and those treated at home (76). 
The third approach to establishing the prevalence is from hospital 
statistics, to multiply the mean hospital rates of fatal and non fatal 
embolism by the number of inpatients. A reasonable overall 
estimate of the incidence of fatal embolism based on necropsy 
studies is about 5 per 1, 000 inpatients and for non fatal embolism 
about 10 per 1000 inpatients (76). For England and Wales with 
4. 2 million hospital inpatients, this would give about 21,000 fatal 
and an additional 42, 000 non fatal cases of pulmonary embolism. 
From the United States with 28. 5 million short-term inpatients, 
this would give 142,000 fatal and an additional 285,000 non-fatal 
cases of pulmonary embolism (76). These figures are greater 
than the estimates made by Coon and Willis (77) from the US of 
about 47,000 deaths from pulmonary embolism as a sole cause, 
and three times as many contributing to death. The number of 
persons with clinical thrombosis is also difficult to assess. 
Those with the diagnosis of thrombo-phlebitis in the US hospitals 
in 1966 were estimated at 182,000 (76). 
37 
3. FREQUENCY OF DEEP VEIN THROMBOSIS 
1. Clinical Incidence 
2. Post Mortem 
3. Newer Methods of Diagnosis 
1. Clinical Incidence 
In a review of the literature Bruzelius (79) found the postoperative 
frequency varied from O. 6 to 3. 5 per cent. Clinical thrombosis 
was found in 12 to 15% patients with fractures or soft tissue 
injury to the lower limbs (80, 81). Barker in 1941 studied 
158,200 medical, surgical and gynaecological patients, and 
found an overall incidence of deep vein thrombosis in O. 95%, 
of these O. 5% developed pulmonary embolism, and O. 2% were 
fatal (82). Sevitt {78) in a combined clinico-pathological study 
in 1961 estimated that as many as 2 out of 3 deep vein thromboses 
were symptom-free, and found no clinical evidence of venous 
thrombosis in 50% of patients dying of pulmonary embolism (11). 
The insensitivity of clinical diagnosis was suspected in 1941 
by Welch and Faxon who· fo.und that only 5% of fatal pulmonary 
emboli had clinical evidence of deep vein thrombosis (101). 
McLachlin {88) in 1962 compared the clinical physical signs 
of thrombosis with post mortem findings and found that 
- ankle oedema - was reliable in 80%, but Gibbs (89) 
in 1957 found that it was 100% reliable if there was 
occlusion of the ilio -femoral or ilio-caval veins. 
local tenderness - was reliable in 50% of cases 
positive Homans' sign - was reliabie in 8% of cases 
pyrexia and tachycardia - was very unreliable 
late pain - was perhaps the most important symptom 
• 
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Furthermore the signs of thrombosis may be present in the 
absence of a thrombus (4). 
2 . Post Mortem Incidence of Deep Vein Thrombosis 
The incidence of deep vein thrombosis reported at necropsy 
ranges from 27 to 80%. See Table I. Some differences are 
related to the completeness or otherwise of venous dissection 
and in most series the frequency will range from 44 to 65%. 
{76, 86, 89, 90}. The incidence does not seem to depend upon 
the sex or directly on clinical diagnosis and the evidence 
indicates the likelihood of thrombosis is similar in medical, 
surgical or traumatic cases with other factors being similar {76). 
The frequency of thrombosis in any series of post mortems 
depends on the ages and survival period {bed rest} of the patients(76). 
This explains at least some of the differences reported in the 
table and also differences in the frequency between e.g. those 
dying from fractured neck of femur {83%), head and chest 
injuries {37%) and burns {60%}. The lowest figure was 
associated with a large proportion of cases with short survival, 
the very high rate is related to relatively long survival period 
combined with advanced age .. Survival and prolongation of 
life may also be related to therapy which vould then indirectly 
influence the frequency of thrombosis. From the 11 published 
series in Table 1 of 2,460 patients the overall incidence of 
deep vein thrombosis at post mortem was 56%. 
• 
Table 1. Incidence of Deep Vein Thrombosis of the Lowe r Limbs 
at Post Mortem 
Number Percent 
References of Nature of with deep Notes 
necropsies Case Vein Thrombi 
Rclssle {83) 324 Consecutive 26 Cases of sudden 
miscellaneous death without 
cases over preceding bedrest 
20 years old 
Neumann {84) 165 Miscellaneous 60.6 Dis section of 
deep thigh and 
calf veins. 
Putzer ( 85) 370 Miscellaneous 27 Calf veins only 
examined 
Hunter {86} 351 Medical and 52 . 7 Dissection of 
Surgical deep thigh and 
calf veins 
Hunter et al. {86} 200 Medical and 59 Dissection of 
surgical deep tligh and 
calf veins 
200 Medical and 44 
surgical 
Greenstein {8 7) 100 Miscellaneous 51 Calf veins 
mainly Medical dissected 
McLachlin (88) 100 Male subjects Dissection of 
over 40 years old 34 deep thigh and 
calf veins 
Gibbs (89) 253 Medical, surgical, 59 Dissection of 
and traumatic deep thigh and 
calf veins. 
Sevitt and Gallagher (11) 39 Elderly patients 80 Dissection of 
with fractured deep thigh and 
neck of femur calf veins 
( Continued) / ••••• 
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necropsies Nature of Case 
Fractured neck of 
femur 




Head or head and 
chest injury 
Other injuries 
92 Total trauma 
cases 
33 Burns 
125 Trauma and burns 




























age over 45 
;ears. 
is section 
of deep thigh 
and calf veins. 
• 
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Pulmonary Embolism at Post Mortem 
Table II gives the findings from 16 published series of the incidence 
of pulmonary embolism at post mortem. 
In some series the total incidence may represent major embolism 
rather than the fatal incidence because the pathological criteria 
for fatal emboli may vary between pathologists . 
The overall frequency ranged considerably from 1. 8% (94) to 
67% (99), but in most embolism was found in 10 to 30%. 
Pulmonary embolism which was fatal or contributing to death, 
the range was also very wide from 2% (93) to 25% (89), but was 
generally 3 to 10%. 
The frequency is influenced by many factors which include the 
amount of detailed dissection and histological confirmation (99, 100), 
and preceding clinical composition of the patients (76). 
Authors (86, 87, 88, 98, 99) who present figures drawn from 
incidences are agreed on three points. 
i. Thrombosis of leg veins when it occurs, is bilateral 
in a high proportion. Often a thrombosis is extensive in one 
leg and slight in the other i.e. clinically manifest or clincially 
silent respectively. 
ii. Pulmonary emboli which are fatal or non-fatal are almost 
never found in the absence of a peripheral source of thrombosis 
in the limbs, if these limb veins are properly dissected out. 
iii. Untreated pulmonary embolfaation tends to be a repetitive 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Is Pulmonary Embolism Increasing? 
The number of deaths from pulmonary embolism are greatly 
underestimated by the international method of recording based 
on medical certification, nevertheless published figures show 
an increase since 1946, especially rapid from 1952 and still 
continuing (75) . 
. The graph in Figure 5 though imperfect and selective, suggests 
a genuine rise in the frequency of fatal pulmonary embolism 
in England and Wales since the end of the Second World War. 
Morrell et al (98) reached a similar conclusion, of a real increase 
on the basis of a retrospective analysis of records from two 
general hospitals in Oxford from 1952 to 1961 in which 90 percent 
were confirmed at post mortem. 
3. Newer Methods of Diagnosis 
The incidence of postoperative deep vein thrombosis using 1
125 
Fibrinogen in 10 different centres gave an overall incidence of 
30% as shown in Table III. However, it must be stressed that 
h I 
12 5 F · b · · f h d. . f h lf d 1 t e - 1 r1nogen 1s or t e 1agnos1s o t e ca an ower 
thigh venous thromboses and not the upper thigh or pelvic. 
FIGURE 5 ANNUAL DEATHS FROM PULMONARY 
EMBOLISM IN ENGLAND AND WALES 
From Registrar-General's Reports {75) 
• 
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Table III 
Incidence of Deep Vein Thrombosis diagnosed with 1125 
Fibrinogen Technique 
Type of Number of 
Author operation patients Age Thrombi % 
Flanc in 1968 Elective 65 ) 40 23 · 35. 4 
{19) Surgery 
Negus in 1968 Major Surgery 93 ) 50 32 34.4 
{8) 
Kakkar in 1969 Elective 132 ) 40 40 30.3 
(24) Surgery 
Browse and Moderate or 110 )40 23 20. 9 
Negus in 1970 (6) Major Surgery 
Lambie in 1970 Major Abdominal 111 )40 49 44.1 
{7,23) and Hip Surgery 
Hedlund in Transvesical 31 ) 50 11 35.5 
1971 (103) Pro statectomy 
Rosengarten Elective Surgery 38 )40 12 31. 6 
in 1971 {20, 104) 
Tsapogas in 1970 Major 20 )40 6 30.0 
{ 105) Surgery 
Becker in 1971 Transvesical 30 )50 10 33.3 
{ 102) Pro statectomy 
Cholecystectomy 60 ) 50 9 15.0 
Kemble in Major Surgery 280 )40 80 28.0 
1971 (4) 
TOTAL 970 30. 0% 
4 8 
Evans and Cockett (32) in 1969 compared ultrasound, clinical 
125 
diagnosis, phlebography and I Isotopic studies. Of 19 legs 
thought clinically to have deep vein. thrombosis, 8 were positive 
by ultrasound compared with 10 positive by phlebography or 
isotopic studies. In 19 clinically normal legs, two were 
positive by ultrasound compared with three positive by 
phlebography or isotopic studies. Similar results were obtained 
by Evans (33) in a series in which there were no false positives. 
In Mcllroy's series (38) in 322 legs, 16 were positive giving 
an incidence o f 5%. In this series only half the patients who 
were though to have deep vein thrombosis on clinical grounds 
were shown to have a positive deep vein thrombosis by ultrasound. 
More significantly however, over 50% of those which were shown 
to have deep vein thrombosis by ultrasound, were judged clinically 
to be negative. Yao (35) examined 50 patients with chronic 
swol1en legs, of 15 patients with normal ultrasound findings, 
13 had normal patent iliac veins on iliac phlebography i.e. 
80%. Thirty-three patients who had abnormal ultrasound 
findings were found to have complete or incomplete iliac vein 
thrombosis i.e. 100% diagnosis. 
He felt that the Doppler ultrasound method was of special value 
in selecting patients with swollen limbs for radiological 
investigation. Strandness (34) used the Doppler ultrasound 
in 112 patients who presented with clinical evidence of deep 
vein thrombosis. Result of ultrasound tesing programme was 
confirmed in 67 venograms in 53 patients and by operation an 
additional 4 patients. The correlation of Doppler ultrasound 
with venography was 93%. The Doppl er ultrasound is useful 
for occlusion in the ilio-femoral and femoro -popliteal segments 
of veins. Negative examinations occur with venous occlusions 
confined to the small veins of the calf ( 10, 34). 
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The incidence of deep vein thrombosis occurring m fractures of the 
hip or lower extremity as_ diagnosed by Venography is shown in Table IV. 
The overall incidence in 356 cases from seven centres was 48%. 
Venography gives the most reliable and accurate incidence of 
postoperative deep vein thrombosis and confirms the cli.rucal, I
125 
fibringgen and Doppler ultrasound methods. It visualises the whole 
venous system from the ankle to iliac and even inferior cava {50). 
Table IV Incidence of Deep Vein Thrombosis Diagnosed by 
Phlebography 
Number of 
Author Injury Diagnosis Patients Age Thrombi % 
Ahlberg in Hip Phlebography 99 )50 44 44 
1968 (106) fractures 
Borgstrom Hip Phlebography 25 ) 50 14 56 
in 1965 (107) fractures + 
Autopsy 
Hamilton in Hip Phlebography 38 )50 18 48 
1970 (108) fractures 
Hjelmstedt and 
Bergvall in Tibial Phlebography 43 )40 24 56 
1968 (109) fractures 
Johnson in Hip Phlebography 25 )50 13 52 
1968 (110) fractures 
Myhre and Hip Phlebography 55 )50 22 40 
Holen in fractures 
1969 (111) 
Stevens in Hip Phlebography 71 )50 28 40 
1968 {112) fractures 
TOTAL 356 48% 
III. 
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PREVENTION OF POSTOPERATIVE DEEP VEIN 
THROMBOSIS 
Preoperative, Peroperative, Postoperative 
INTRODUCTION 
I. SIMPLE MEASURES TO IMPROVE BLOOD FLOW THROUGH 
THE LEG VEINS. 
2. ELECTRICAL STIMULATION O F THE CALF. 
3. MOTORISED FOOT MOVER FOR RHYTHMIC PASSIVE 
MOVEMENT OF FOOT. 
4. PNEUMATIC COMPRESSION OF CALF. 
5. ORAL ANTICOAGULANTS. 
6. HEPARIN -
a. Full Dose 
b. Low Dose 
Subcutaneous, intramuscular or intravenous. 
7. DEXTRAN -
a. Dextran 40 
b. Dextran 7 0 
8. SODIUM PENTOSAN POLYSULPHATE "TAVAN - SP 54" 
'). MISCELLANEOUS -
a. Antiplatelet agents 
I. Aspirin 
2. Hydroxychloroquine Sulphate 
3. Dipyridamole. 
b. Endogenous Fibrinolysis -
Phenformin and Anabolic Steroid 
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Introduction 
The new diagnostic methods have disclosed a high incidence of 
postoperative deep vein thrombosis (4, 19, 26, 28) . 
Many of the thrombi form on the operating table and within 
the first 24 to 48 hours (26). This new information assists 
in defending methods for the prevention of deep vein thrombosis. 
The prevention must be subdivided into 
1. Preoperative - which is by far the most important, 
2. Interoperative - or peroperative and 
3. Postoperative measures. 
Virchow's Triad (113, 114) despite extensive investigations into 
the aetiology and pathophysiology of deep vein thrombosis is 
still valid ( 115) and consists of i) slowing of venous blood 
flow i.e. stasis. 
ii) changes in blood coagulability and 
iii) vessel intimal damage. 
Methods of preventi::m of deep vein thrombosis have been slow 
to develop for two reasons, because 
a. the aetiology is poorly understood, therefore 
attempts at prophylaxis are difficult and 
b. problem of objective assessment within the past, when 
many erroneous claims were made and later discredited. 
The number in many series are too small to make definite 
conclusions, although the general impression conveyed in 
several studies are that the complications are less frequent 
• 
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m the treated group . 
The significance of clinical studies may lie in the incidence of the 
major complications such as pulmonary emboli rather than a 
total incidence of deep vein thrombosis. 
All the methods of prevention to be discussed are aimed at preventing 
and treating one or more of the factors involved in Virchow' s 
Triad ( 113 ). 
1. SIMPLE MECHANICAL MEASURES TO IMPROVE BLOOD 
FLOW THROUGH THE VEINS. 
J'he evidence that simple prophylactic measures are effective 
in reducing the incidence of deep vein thrombosis is conflicting. 
Some workers say it is of value ( 116, 117) while the . others 
deny this (118,119). Unfortunately these conclusions are based 
on physical signs which are quite inadequate in the diagnosis 
of venous thrombosis (19). In a study by Flanc (120), 65 
patients received conventional prophylactic measures and the 
incidence of deep vein thrombosis was 35%. More intensive 
measures, designed to protect the legs from pressure and to 
promote venous flow during and after operation were used in 
67 patients. The incidence of deep vein thrombosis in this 
group was 25% and the difference was not significant (P=O. 25). 
However in elderly patients undergoing a major operatbn there 
was a significant reduction in the incidence of venous thrombosis 
from 61% in the control group to 24% in the test group. 
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Prophylactic Measures 
a. Before operation controls seen by physiotherapists on the day 
before operation and were taught to do active leg exercises and 
static quadriceps contractions. Thick below knee elastic 
stockings were fitted and worn throughout the patient's stay in 
hospital and the patients were instructed to perform exercises 
constantly, but with special vigour for five minutes in every 
hour. The foot of the bed was elevated to 23 ems on blocks 
and a foot board placed in the bed so that plantar flexion could 
be performed against resistance. 
b. During operation elastic stockings were worn and pressure 
on the calves was prevented by the use of specially devised 
Sorbo-rubber stands. After the operation, the legs were kept 
elevated by this stand while the patient was carried to the ward, 
and until they are cons ci:>us and able to perform active leg 
exercises. 
c. Postoperative period. 
Patient was seen by the physiotherapist twice a day until 
allowed to walk. They were encouraged to move their legs 
vigorously and to push against the footboard. Patients 
were constantly reminded of their exercise schedule of 5 
minutes in every hour by the nursing staff. All patients 
were instructed in deep breathing exercises before and after 
operation. A period of intensive physiotherapy does cause 
an increase in spontaneous resolution of the thrombus which 
125 
has been shown by I Fibrinogen (2. 5 instead of 6 days) {120}. 
Results however show that leg exercises as performed twice 
daily in the surgical wards in many hospitals do not prevent 
thrombosis (120}. 
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Leg elevation during and after operation does not reduce the 
incidence of deep vein thrombosis in patients undergoing 
elective surgery over the age of 40 years. The incidence 
was 31% in the control group and 33% in patients in whom 
the legs were elevated {20). 
Study carried out by Sigel et al ( 121) showed that elastic 
stockings in inactive recumbent patients increased the femoral 
venous flowvelocity during periods of compression up to 3 hours. 
This increase in blood flow velocity persisted up to 30 minutes 
after removal of stockings. Compression reduced the 
fluctuation effects of respiration on the venous flow, resulting 
in a more constant flow. Their findings indicated that 
elastic compression of the lower extremities produced 
increased venous flow velocity and decreased venous pooling 
which may reduce the recurrence of venous thrombosis. 
However Rosengarten {20) showed that compression stockings 
{Tubi-grip) did not prevent deep vein thrombosis after operation. 
2. ELECTRICAL STIMULATION OF THE CALF 
Doran {122) showed that the velocity of the venous blood flow 
in the leg reached its lowest level during operation and he felt 
that this was the most important period to try and increase it. 
The velocity of venous blood flow could be increased by 
stimulating the calf muscles with an intermittent galvanic 
current. Doran and White ( 123) reported the results of a 
clinical trial of the effect of this method on the incidence of 
deep vein thrombosis and pulmonary embolism. Their 
results were encouraging but not entirely acceptable because 
the diagnosis of deep vein thrombosis was based on physical 
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signs, a method of assessment which has been shown to be 
notoriously unreliable ( 19). In a prospective trial carried out 
by Browse and Negus (6), electrical stimulation of the calf 
muscle of one leg was used in 110 patients undergoing major 
surgery. Deep vein thrombosis was detected by means of the 
1
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fibrinogen uptake test in 9 of the stimulated legs and 23 
of the unstimulated legs. Analysis showed a statistically 
significant reduction in the incidence of deep vein thrombosis. 
This finding was confirmed by Nicolaides (124) using optimal 
electrical stimulation. However in a study by Moloney (125), 
of 285 patients and Dejode {126) in 64 patients undergoing major 
surgery, there was no signficant difference in the incidence 
of deep vein thrombosis. 
The instrument used is called a 1 ' Thrombophylactor'' · produced 
by Rank Precision Industries and Stanley Cox Medical Equipment, 
England. The difficulties encountered are to have the precise 
control of the site and intensity of the stimulus needed. 
Furthermore it depends on the anaesthetic condition, for if 
the patient is curarised, then it is ineffective. Cases of skin 
erythema and blistering have been recorded. 
In summary, electrical stimulation of the calf probably results 
\ 
in a negligible difference in the incidence of postoperative 
deep vein thrombosis. 
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3. MOTORISED FOOT MOVER FOR RHYTHMIC FLEXION OF 
THE FOOT 
Passive flexion of the foot has several advantages, it mimics 
active contraction by producing compression of the calf veins, 
the flexion can be precisely controlled in terms of rate and 
amplitude, it will not produce electrical interference, and its 
effects were not markedly dependent on the anaesthetic condition 
of the subject (22 ). The machine consists of a foot board which 
is attached in the region of the ankle. The foot is held in contact 
with the board and controlled oscillations are produced by 
electrically driven crank mechanism. Roberts showed that the 
peak femoral blood flow could be increased twice its normal 
value and that its pulsatility could be increased eleven-fold (127). 
The passive flexion is begun with induction of the general 
anaesthetic and continued throughout the entire operation and 
can be continued postoperatively. In a series of 41 patients, 
there was a decreased incidence of early thrombosis by 77% (22). 
However the study was too small for any definite conclusbns and 
requires further investigation. The mechanism of decreasing 
the incidence of deep vein thrombosis by this method is unknown, 
but it may be due to an increase in the pulsatile venous flow 
or just increase in the volume of blood flow (127). The machine 
produces a continuous dorsal and plantar flexion at 50 cycles 
per minute at the amplitude of 20° to the vertical (22). 
4. PNEUMATIC INTERMITTENT COMPRESSION OF THE CALF 
Calnan designed a tubular legging which compresses the calf 
and foot at 40 mm. Hg pressure intermittently three times a 
minute (21). 
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The pneumatic pressure is generated from a standard electrical 
pump which is almost silent and could hang at the end of the bed. 
From their initial studies, they concluded that intermittent 
compression of the calf muscles, rhythmically altered volume 
of blood flow in veins of the leg. 
calf muscle pump (21). 
Thus mimicing the normal 
A study undertaken by Hills with a modified apparatus consisting 
of a single piece of P. V. C. legging incorporating the foot and 
calf in a unitory design, was carried out in 100 patients ( 128 ). 
The electric pump inflated each leg alternately so that a 
compression at 40 to 45 mm Hg. for one minute was achieved 
followed by relaxation for one minute. The apparatus was 
applied preoperatively at the time of giving the premedication, 
continued peroperatively and for one day postoperatively. 
They found that in patients suffering from malignant disease 
there was no decrease in incidence of deep vein thrombosis. 
In those patients not suffering from malignant disease, there 
was a decrease in the incidence. They concluded that it was 
a safe, effective and practical method of preventing postoperative 
deep vein thrombosis. In their study both legs were used 
and the patients were divided into two groups ( 128 ). Sabri 
carried out a study in which one leg of each patient was used 
as a control. Their results in 39 patients showed that the 
increase in the pulsatility of the venous flow in the leg was a 
potent prophylaxis against deep vein thrombosis {129). 
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In Summary, these mechanical methods are aimed to reduce 
the thrombi occurring during the operation and within the fir st 
48 to 72 hours postoperative by preventing stasis of blood in 
the lower limbs. 
Simple mechanical measures are inadequate alone; electrical 
stimulation has complications and the results are inconclusive 
(22, 126). 
The motorized foot mover and pn eumatic intermittent compression 
of the calf appear to be effective but further studies are necessary 
(22, 128, 129). 
5. ORAL ANTICOAGULANTS 
Pinto showed that if sodium warfarin was given with the 
premedication there was no decrease in the incidence of deep 
vein thrombosis in patients undergoing hip surgery (130). 
The probable reason for this negative result was that it takes 
48 to 72 hours for oral coagulants to take effect. However, in the 
study by Lambie (30) in which 30 mgs of sodium warfarin was 
given 36 hours preoperatively and subsequent doses were 
adjusted with prothrombin time, he found that 12 out of 40 
patients developed deep vein thrombosis, six of which were 
extensive, six minor and bleeding was a definite complication. 
In summary, oral anticoagulants such as Warfarin probably 
have no place in the prevention of deep vein thrombosis even if 
given preoperatively and have the risk of side effects. 
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6. HEPARIN 
Many reports have appeared in the literature in the last three 
years on the use of heparin even given intravenously, 
intramuscularly or subcutaneously (1, 3, 5, 131, 133, 134). 
Various studies have been undertaken using high dose heparin 
which alters the clotting and prothrombin time or small (low 
dose heparin) which does not affect the prothrombin or clotting 
time, but appears to increase the quantity of naturally 
occurring inhibitors of coagulation {135, 136, 137). 
Anticoagulation in full heparin doses increases the risk of 
bleeding both at operation and postoperatively, and thus is an 
impractical proposition (138,139). Kakkar et al (131) reported 
the use of small dose subcutaneous heparin in 1971, as concentrated 
aqueous calcium heparin ( 11 Calciparine 11 ), which is in a solution 
of 2 5, 000 units per cc. They gave 5, 000 units of heparin two 
hours preope·ratively and in first 24 hours postoperatively, 
followed by 12 hourly injections for the next five days. 
In their study, the incidence of deep vein thrombosis decreased 
from 26% to 4%. Sharnoff ( 140) who began this work 10 years 
before showed that this treatment largely prevented fatal 
pulmonary emboli. 
Mechanism of Action 
In the dosage used heparin increases the circulating level of 
two naturally occurring inhibitors of coagulation i.e. antifactor 
Xa and antithrombin III and reduces platelet adhesiv eness 
{135, 136, 137). 
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Clinical studies 
The ability of subcutaneous low dose heparin to prevent 
postoperative deep vein thrombosis, has now been assessed in 
a number of well controlled trials in which 1
125 
fibrinogen 
tests have been used to detect thrombosis (See Table V). 
In all the trials, the incidence of positive tests indicating deep 
vein thrombosis, was much lower than the controls. In 
William's trial (5) the difference was somewhat obscured 
by the high incidence of positive tests after prostactectomy 
in both treated and controlled groups. However, in the 
study by Gordort-Smith (9), there was no evidence of thrombosis 
in 6 patients who had retro-pub.ic . prostatectomies. 
Furthermore, the total incidence of positive tests 
treated for only one day after operation did not differ 
significantly from that in patients treated for five days (9), 
However, in the patients who had ".nalignant disease, the 
incidence of positive tests was reduced only by the longer period 
of treatment (9). The largest and most recently published 
trial by Nicolaides ( 133) has provided the first clear link 
between the incidence of positive fibrinogen tests and that of 
thrombi extending dangerously into the proximal veins. 
Such a thrombus was found in 9 patients in the control group and 
none in the heparin-treated group, a highly significant 
difference. None of the patients in the trial developed signs 
of pulmonary embolism, the 9 patients with the extending 
thrombi were tr_eated with anticoagulants ( 133 ). Relatively 
few positive tests for deep vein thrombosis were also fcund 
in a series of 133 patients considered to be a high risk of 
postoperative thrombosis by Kakkar (1), all of whom received 
low dose heparin. The results were similar between the 
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patients who had benign or malignant disease (1). However, 
positive tests were seen in 40% of 50 patients having operations 
for fractured neck of the femur (1). The failure of low dose 
heparin to protect patients with femoral neck fractures or 
cardiac infarction is plausibly explained by the activation of 
factor X, which follows tissue damage. Once this has 
occurred, much higher doses of heparin are required to 
neutralise it (141). 
Dose 
Low dose subcutaneous heparin is given in dose of 5, 000 units 
one or two hours before ope ration and 12 hours thereafter for 
5 to 7 days by deep subcutaneous injection ( 131). 
Complications 
No co~plications were reported by Kakkar ( 131) and Williams ( 5 ). 
Wound haematomas developed in four percent of treated patients 
in Gordon-Smith's study (3 ), but in a larger trial by Nicolaides ( 133 ), 
they occurred with equal frequency in the controls and treated 
patients. Troublesome bleeding was reported in two trials, 
the incidence being 1 out of l 23 patients treated ( 133) and 3 
out of 222 (1). 
In all four patients there were other factors which may have been 
partly responsible. 
Braising at the injection site did not give rise to many complaints, 
even when doses of 7,500 units were given 12-hourly {142). 
In some trials, calcium heparin was used because it apparently 
causes less local bleeding (1,131). In others, sodium ljeparin 
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caused haematoma at the injection site in only 6 out o f 222 
patients, and in 4 of these the injection was given incorrectly 
(3,133). 
Conclusion 
Low dose subcutaneous heparin in the dose of 5, 000 units 
one or two hours before operation and 12 hours thereafter 
for 5 to 7 days lowers the incidence of postoperative deep 
vein thrombosis after most major operations. Prophylactic 
effects have not been found in patients with fractured neck of 
femur or with cardiac infarction, presumably because in these 
condit:i.ons the dose of heparin is too small to neutralise the 
factor X, which has been activated by previous tis sue damage. 
Lowering the incidence of deep vein thrombosis, as shown by 
the radioactive fibrinogen tests, is likely to reduce that of 
pulmonary embolism, but this can be proved only by large -
scale studies. 
to administer. 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































a. Dextran 40 ("Rheomacrodex") 
b. Dextran 70 ("Macrodex") 
Dextrans are polysaccharides produced by bacterial interaction 
on sucrose. The two clinically available dextrans are Dextran 70, 
which has an average molecular weight of 70, 000 units ( "Macrodex") 
and Dextran 40, with an average molecular weight of 40,000 units 
( "Rheomacrodex"). For surveys of the metabolism and 
excretion of dextran as well as other biological effects not 
connected with antithrombotic properties, there has been an 
extensive review on this subject given by Ingelman (14~). 
The antithrombotic effects of dextran are well documented 
both clinically and experimentally but its mode of action is 
still a matter of discussion. It may be due to an effect on 
the coagulation mechanism, the· platelet function, the vessel 
endothelium, fibrinolysis or on blood flow (115). 
The antithrombotic effects of dextran cannot be explained by 
its anticoagulant properties (115). From investigation it 
appears that dextran has a depressive effect on platelet 
function, and this may be the main cause of a slightly 
increased bleeding time reported by some authors (115,144). 
Whether dex tran has any fibrolytic properties is still a matter 
of discussion ( 145). Gelin noted the improvement of blood flow 
and a counteraction of postcapillary venous stasis ( 146). 
Kockenberg in 1961 published the first report on the clinical 
use of dextran for the prevention of postoperative thrombo-
embolism in general surgery (147). 
A review of the results in most of the clinical trials is given 






















































































































































































































































































































































































































































































































































































































































In 1968 several papers were published reporting good prophylaxis 
using dextran in connection with orthopaedic and general surgery 
(147,110). In patients with hip fractures the average incidence 
of venous thrombosis was about 50% and dextran could decrease 
these complications by 80%. All patients were checked with 
phlebography. 
A conclusive study was reported by Lambie et al 197 0, in which 
8 0 patients over the age of 40 years were operated on for 
major gynaecological surgery and divided randomly into two 
groups {23). One group was treated with Warfarin Sodium 
and the other group received Dextran 7 0 in saline. 
The diagnosis of deep vein thrombosis was made using 
labelled fibrinogen. In the warfarin group 6 major and 6 minor 
thromboses were diagnosed, and in the dextran group there 
were no major, and only 4 minor thromboses {23). 
From Table VI , it will be seen that dextran 70 appears superior 
to dextran 40 in preventing venous thrombosis. This is 
probably due to the antithrombotic properties, rather than 
improved blood flow and plasma volume expansion {115). 
The most conclusive report is that from Jansen (llS) in which 901 
cases were studied in a double blind trial. 
Postoperatively the patients were followed clinically with 
bedside examinations of the lower extremities. In all cases 
of even slight suspicion of venous thrombosis ascending 
phlebography was performed. In the 901 cases studied, 301 
were in the control group, 304 in the dextran 7 0 group and 
296 in the dextran 40 group. In the control group, I 0% of the 
cases developed postoperative deep vein thrombosis which was 
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confirmed on phlebography. ( 6 pulmonary emboli, 5 major 
emboli). The incidence in the dextran 7 0 group was 5. 9% 
{18 cases, 4 with pulmonary emboli, 1 major emboius. ) 
In the dextran 40 group 4. 4% {13 cases, no emboli). Jansen 
concluded that the difference in incidence of thrombosis 
between the dextran groups and the control group was 
statistically significant. The prevention seemed to be most 
effective with dextran 40. There was no statistically 
significant difference however between the two dextran 
preparations. Further analysis of the results showed that 
the preventive effect was most pronounced in 489 patients 
with an operation time of 1 hour or less. In the remaining 
patients with an operation time of more than one hour, the 
effect of 500 ml of dex tran was no longer significant, 
probably indicating that the dextran dosage used was 
insufficient in such cases. 
In a later study, when the test solut ions were given the day 
after operation, the frequency of postoperative thrombo-embolism 
was equal in all groups {115). Jansen concluded from his study 
that the admin istration of 1 single unit of 500 ml of dextran 
in the course of an operation of one hour or less, wa.s a simple 
and safe way to decrease the incidence of thrombo-embblic 
complications, in general surgery {115). 
Side effects induced by Dextran 
1. Increased bleeding tendency during the operation was not 
observed in the trial by Jansen ( 115 ). 
2. Acute reactions to dextran infusion have been reported _ 
and the Swedish Adverse Drug Reaction Committee have 
collected 64 cases from an international survey {156). 
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3. Dextran is contraindicated in patients with congestive cardiac 
failure, bronchospasm or renal failure ( 115 ). 
8. SODIUM PENTOSAN POLYSUil?HATE ''TAYAN-SP 54'' 
This is a polysaccharide, synthetic heparin-like sulphated 
polyanion. Several studies have been undertaken which show 
that it causes an inhibition of platelet aggregation, is anti-
thrombotic, and acts as a clearing factor ( 157 ). The only 
clinical trial using Tavan-SP 54 was published by Kraft in 
1962 in the prevention of postoperative deep vein thrombosis ( 158 ). 
The dose used was 50 mg intramuscularly 12 hourly starting 
on the evening of the first postoperative day. 
Results 
In 3,752 cases of patients treated prophylactically over a period 
of four years, an incidence of less than 1% of deep vein 
thrombosis, and of these 0. 08% were lethal. 
The control incidence of deep vein thrombosis was 3.15%, 
and of pulmonary emboli 1. 5% , with a mortality of 0. 3% 
over a seven year period comprising 15, 000 operations. 
However the diagnosis of deep vein thrombosis and pulmonary 
emboli were on a clinical basis which by todays standards 
are inacceptable. The remaining work on the use of Tavan-
SP 54 has been done in animals ( 15 7). 
71 
9. MISCELLANEOUS 
A. Antiplatelet agents 
These are relatively free from side effects and therefore may 
have a more im_portant role than anticoagulants. 
1. Hydroxychloroquine Sulphate 
This had been shown to decrease platelet aggregation. 
Initial work was done by Knisely ( 160) in 1941 and Madow ( 161) 
in 1960 when it was used as an anti-malarial drug to decrease 
the red blood cell sludging. In the two groups studied by 
Carter (159) in 1972 the one was diagnosed clinically and the 
other by phlebography with a statistically significant decrease 
in the incidence of deep vein thrombosis and pulmonary emboli. 
The dose was 200 mgs of hydroxycholoroquine sulphate 
intramuscularly with the premedication and then 8 hourly 
intramuscularly or orally until discharged (159). 
There were no complications, but the group was small and 
one awaits further results. 
2. Dipyridamole 
This initially showed some promise, but has now been shown 
to be unsatisfactory (161A). 
3. Aspirin 
A report by Steering Committee of a trial sponsored by the 
Medical Research Council, done as a double blind randomised 
study of the effect of aspirin on postoperative deep vein 
thrombosis ( 162). 
There were 303 patients over the age of 2 7, who were admitted 
to four hospitals for elective surgery and received 
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either 600 mgs of Aspirin or a placebo during the 24 hours 
preceeding operation and on the first 5 postoperative mornings. 
Deep vein thrombosis was diagnosed by r125 fibrinogen uptake 
tests and the results showed no significant difference between 
the treated and placebo groups ( 162 ). 
A smaller trial using 600 mgs, 4 times a day was also undertaken 
but the incidence of deep vein thrombosis remained unaltered. 
B. Stimulation of endogenous fibrinolysis pharmacologically 
After surgery there is a period of reduced fibrinolytic activity, 
the so called "fibrinolytic shut-down" (163). It has been shown 
that administration of Phenformin and Ethyloestrenol increases 
endogenous blood fibrinolytic activity as measured by the clot 
lysis time {164). The study by Brown (165) in 1971 in 
which two groups of 27 patients were studied, one group was 
given six weeks of preoperative, followed by 10 days of 
postoperative treatment with Phenformin 50 mgs twice daily 
and Ethyloestrenol (an anabolic steroid), 4 mgs twice daily, 
and the other was not. Their results showed an increase in 
the fibrinolytic activity by the clot-lysis time and an increased 
level of fibrin-degradation products. This could be a useful 
method of preventim and a trial has now been undertaken by 
Brown (165). The disadvantage is however, that the patient 
must be prepared 6 weeks before surgery. 
Summary of drugs used m the prevention of postoperative 
deep vein thrombosis. 
Many studies have been undertaken. If the efficacy of low dose 
subcutaneous heparin is confirmed in our own patients then a 
turning point would have been reached in the prevention of 
postoperative deep vein thrombosis. 
Coumadin, aspirin and dipyridamole are ineffective and dextran 
appears to have a place in selected patients. 
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3. MATERIAL 
THE TOTAL NUMBER of patients included in this study were 
298 patients. 
Sub-division of patients into 
1. CONTROL GROUP IN GENERAL SURGERY 130 
2. NEUROSURGERY 23 
3. OPHTHALMOLOGY AND OTOLARYNGOLOGY 31 
4. CALCIUM HEPARIN TRIAL 54 
5. SODIUM PENTOSAN POLYSULPHATE TRIAL 60 
• 
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CONTROL GROUP IN GENERAL SURGERY 
All patients in the control group underwent an operation 
requiring a general anaesthetic. Ninety percent of the 
patients were over the age of 40 years and were to undergo 
a major elective surgical procedure. A major operation 
was defined for the purpose of the trial as any surgical 
procedure performed under general anaesthesia wlich 
lasted more than 30 minutes and which would be followed by 
at least seven days in hospital. Patients excluded from the 
trial were those undergoing surgery to the lower limb and 
those undergoing left mastectomy, because of the difficulty 
in radioactive fibrinogen counting. 
NEUROSURGICAL PATIENTS 
In this group all patients who were undergoing any neurosurgical 
procedure and spinal operations were included. Similar 
criteria with the procedure being performed under general 
anaesthetic lasting more than half an hour and the patient 
being in hospital for longer than 7 days. All patients 
included in this series were over the age of 21 years. 
OPHTHAIMOLOGICAL AND OTOLARYNGOLOGY PATIENTS 
These patients were selected provided that they had to undergo 
general anaesthetic las ting more than half an hour with at 
least 3 days postoperative hospitalisation. 
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PROPHYLAXIS OF DEEP VEIN THROMBOSIS AND PULMONARY 
EMBOLISM WITH SUBCUTANEOUS CALCIUM HEPARIN 
The criteria for inclusion m this co-operative trial 
associated with King's College Hospital, London we re that 
the patients 
i. age over 40 years undergoing a 
11. major elective surgical procedure. 
Patients excluded were those undergoing 
1. emergency surgery. Those receiving 
ii. heparin for any reason. Those undergoing 
iii. surgery to the lower limb, or 
iv. left mastectomy. 
Two groups of patients were studied. One group received 
prophylactic subcuta -neous heparin and the other group would 
act as a control. Patients were allocated to a group on a 
computerised basis of randomly allocated envelopes, which 
contained a slip on which was printed ''treatment'' or ''control''· 
The proformas and calcium heparin was obtained from the 
Calcium Heparin Trial Centre at the Department of Surgery, 
King's College Hospital Medical School, London, where 
Dr V. Kakkar is conducting a multicentre trial of prophylactic 
subcutaneous heparin. 




Patients in the treatment group received subcutaneous heparin 
in the dose of 5,000 units, 2 hours preoperatively and 8 hours 
after this for the first 6 postoperative days {a total of 7 days 
treatment). If, at the end of the 6th postoperative day, the 
patient was still confined to bed due to any condition (e.g. 
infection) Calcium Heparin was continued in the same dosage 
until the patient was fully mobile . The time of administration 
of the drug postoperatively was adjusted to correspond with 
the ward drug-rounds, provided an 8 hour interval between 
injections was maintained. The injection was given using 
a 26 gauge needle, into the subcutaneous tissue of the anterior 
abdominal wall. A fold of skin was raised and the needle 
inserted at right angles to the skin. After injection the 
needle was withdrawn at the same angle. Other sites e.g. 
arms and thighs were not used for the injection . One sheet 
of the proforma was provided on which administration of the 
Calcium Heparin by the nursing staff was recorded. This 
record was of vital importance to the trial as evidence that 
the drug had been given. 
• 
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SODIUM PENTOSAN POLYSULPHATE OR 11 TAVAN-SP 54 11 
Pati-ents were admitted to this trial who were undergoing 
elec tive major general surgical operations under general 
anaesthesia. Patients were allocated consecutively into 
control and trial groups. 
A. The first part of the study was undertaken using 
high dose of Tavan-SP54 in which 100 mgs was given 
2 hours preoperatively and then 100 mgs was given 6 hourly 
by intramuscular injection. However, due to complications 
of bleeding this was changed. 
B. A second study was made using low dose Tavan-SP 54, 
in which 50 mgs was given 2 hours preoperatively and then 
50 mgs was given 12 hourly by intramuscular injection. 
A total of 60 cases were admitted to this trial, 12 to the 
high dose and 48 to the low dose of Tavan-SP 54. 
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4-. METHOD OF DIAGNOSIS OF DEEP VEIN THROMBOSIS 
1. CLINICAL 
2. RADIO-ACTIVE FIBRINOGEN 
3. DOPPLER ULTRASOUND TECHNIQUE 
4. VENOGRA PHY 
1. CLINICAL 
The classical signs of deep vein thrombosis were sought daily, 
and included calf tenderness and swelling, oedema and duskiness 
of the ankle and Homan' s sign. 
The temperature chart was noted and the patient was directly 
questioned as to any evidence of pulmonary emboli such as 
chest pain, shortness of breath or haemoptysis and the chest 




LABELLED FIBRINOGEN TECHNIQUE 
The thyroid uptake of the radio -active iodine was blocked by 
giving 100 mgs of potassium iodide orally 24 hours before the 
injection of the isotope labelled fibrin ogen and daily thereafter 
or by the intravenous injection of 20 cc' s of a 10 % solution of 
sodium iodide if the patient was taking nil p e r mouth . 
This was followed by injection of 100 m icrocuries of 1
125 
Human Fibrinogen, obtained from a small pool of hepatitis-free 
donors from the Radiochemical C entr e , United Kingdom Atomic 
Energy Authority, Amer sham, England , and was injected 
intravenously. All measurements were made in the ward 
with the patient lying supine in bed, with the legs elevated 10° 
above the horizontal in order to avoid venous pooling. 
Counts were made at selected 5 cm interval points on the lower 
limb and the precordial activity was also noted. Daily counts 
were made. Activity at each point on the limb was expressed 
as a percentage of the heart-count m easured on the same occasion, 
This method eliminated the need for calculating biological or 
radioactive decay. With a Pitman Ratemeter as used in this 
study, the radioactivity at each point on the leg could be 
expressed as a percentage of the heart count by simple use 
of a control which adjusted the precordial counts to a figure of 
100%. This obviated calculations and greatly simplified the 
measurement. The count rate at each one point on the limb, 
expr e ss e d as a perc e ntag e of the heart r a t e m e asured on the 
sam e oc c asion , was c ompared with the r ate at the same point 
on the previous day and w a s also compa r e d with the adjacent 
points on the same limb to the correspo nding points on the 
opposite limb. A ris e of 20% . using the Pitman Ratemeter 
indicated the presenc e of the venous thrombosis, provided 
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lhal the: rise m activity persisted and increased on the succeeding 
d a y. 
3. DOPPLER ULTRASOUND 
The apparatus used was a Sonicaid D. 205M which consisted of 
a portable box which contained a transmitter, receiver, audio-
amplifier, a loudspeaker and a writeout. The transmission 
frequency was 2 megaHertz. The patients were examined sitting 
. 0 
in bed in the ward with the hip fl e xed to 45 • The lower limbs 
were straight and the ankles wer e supported to allow good passive 
filling of the calf veins. A transducer was applied to the 
skin overlying the veins to be examined, using a suitable 
coupling medium such as olive oil. The transducer was sited 
over the common femoral vein and popliteal vein. To produce 
the augmentation or "A wave", the leg was squeezed by the hand 
over the mid thigh and mid calf. Visual recordings of the sounds 
heard were made by attaching the Sonicaid D205M to an electro-
cardiograph machine. If this squeeze was applied to the leg 
d istal to the side of the transducer an acceleration of venous 
flow velocity occur re~ and a roar was heard from the loudspeaker. 
This augmentation or "A wave", indicated the presence of a deep 
venous flow between the site of the squeezing and the transducer. 
The presence of moving blood was ther efore indicated by a 
sound from the loudspeaker while in venous obstruction there 
was silence. For this study it was accepted that either a 
sound was present which indicate d vein patency or the sound 
was absent indicating venous obstruction. 
Patency in the inferior vena cava and iliac veins were assessed 
by applying a Doppl e r probe over the common femoral vein 
during hyperventilation. Absence of obstruction was indicated 
by a wave-like roar corresponding to the respiratory excursion. 
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4. VENOGRAPHY(PHLEBOGRAPHY) 
Venography was carried out routinely in the first 32 patients 
of the control group who were suspected of having deep vein 
thrombosis either Clinically, on Radio-active fibrinogen studies 
or Doppler Ultrasound. The procedure is carried ou.t in the 
Radiology Department of Groote Schuur Hospital. Each leg 
was examined separately. Patients lay supine on the table 
and a tourniquet was applied around the ankle to distend the 
foot veins. A disposable needle was introduced percutaneously 
into a vein of the dor sum of the foot. The needle was directed 
towards the toes i.e. in an up-stream direction. A second 
tourniquet was applied above the knee to trap the contrast 
medium in the calf veins. The table was tilted 20° downwards 
and the legs internally rotated to separate the images of the 
tibia and fibula. The syringe containing 50 ml of the contrast 
medium, Meglumine Iothalamate 60%, was connected to the 
needle by a polythene tube and a hand injection was begun under 
television control. Two exposures were made, one below the 
knee and one including the knee in the postero -anterior 
projection. The third exposure was made with the leg 
externally rotated so that the calf muscle sinusoids were not 
obscured by the tibia and fibula. The upper tourniquet was 
removed and further exposures were taken from the popliteal 
vein to the inferior vena cava. Good filling of the upper 
femoral and iliac veins was obtained by the injector applying 
firm pressure in an upward direction to th e calf. This 
procedure occasionally outlined the lowe r part of the vena 
cavr1. If difficulty was e ncountered a percutaneous transfemoral 
injection of the contrast medium on the non-obstructive side 
was carried out. 
82 
No p c rtrochante r ic i nj ec tions w e r e us e d. Standard bil a teral 
examination d e m o nstrating th e v e nous system from ankle to 
inf e rior vena cava required 200 to 400 ml of contrast medium. 
Af t e r the phlebographic examination was complete the contrast 
medium was cl ea r e d from the venous system with normal 
saline and active m o v ement of the foot. Complete clearing 
of veins was checked by television scree ning. 
5. DIAGNOSIS OF PULMONARY EMBOLISM 
In all suspected cases of pulmonary embolism a full clinical 
examination was carried out. Routine electrocardiogram 
. 131 
plain chest x-ray and lung scan usmg I - labelled 
macro -aggregates of human serum albumin and blood gases 
were measured. Pulmonary angiography and haemodynamic 
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INCIDENCE IN CONTROL GROUP IN GENERAL SURGERY 
OBSERVATION · 
One hundred and thirty cases in the General Surgical Wards 
at Groote Schuur Hospital, Cape Town, were investigated
 
for Postoperative Deep Vein Thrombosis as a Control Group. 
Diagnosis was made Clinically, using Radioactive 
Fibrinogen, Doppler Ultra sound and Venography. 
THE INCIDENCE WAS 51% 
See Figure 6. 
Because of this unexpectedly high incidence, an 
analysis of high risk factors was made. 
In addition, the diagnostic techniques were evaluated 
for accuracy. 
FIGURE 6. INCIDENCE OF POSTOPERATIVE 
DEEP VEIN THROMBOSIS IN THE GENERAL 
SURGERY WARDS AT GROOTE SCHUUR HOSPITAL 
IN 130 CASES. (1972 - 1973) 
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A. FACTORS IN CONTROL GROUP 
In the discussion of these patients the word "Positive" will be 
used for those who developed postoperative de e p vein thrombosis 
and "Negative" for those who did not. 
a. ANALYSIB OF FACTORS 





5. Blood Group 
II. Past History 
1. Myocardial Infarction 
2. Deep Vein Thrombosis 
3. Pulmonary Embolus 
4. Long Bone Fracture in Lowe r Limb 
III. Present Admission 
1. Chronic Obstructive Airways Disease 
2. Contraceptive Pill (Oestrogen and/or 
Progesterone) 
3. Varicose Veins 
4. Varicose Ulcer or Healed Varicose Ulcer 





4. Blood Loss 
V. Postoperative 
1. Complications 
2. Days in Hospital Postoperative 
3. Deaths 
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a. ANALYSIS OF FACTORS 
I. The Patient 
The age distribution of the patients in the control group is 
shown in Figure 7, who developed deep vein thrombosis. 
From the graph it would appear that the 60 to 70 year old 
age group was more prone to develop postoperative deep vein 
thrombosis, but this was not confirmed statistically (0. SO(P ( 0. 75} 
as the numbers were too few. 
However, in dividing the below 40 year and above 40 year old 
age group, there was a statistically significant difference, with 
all patients over 40 years being more prone to develop 
postoperative deep vein thrombosis. (0.05 '( P ( o. 25) 
FIGURE 7. AGE DISTRIBUTION OF POSTOPERATIVE 
DEEP VEIN THROMBOSIS IN THE GENERAL Sl,JRGER Y 
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2, Sex Distribution 
Of the control group 55% were FEMALES and 45% were MALES. 
Postoperative deep vein thrombosis occured in 
54% of the Females and in 
46% of the Males. 
This difference is not statistically significant (0. 25 ( P ( 0, 50). 
See Figure 8. 
3. Racial Distribution 
In the control gro.up 62% were European and 38% were 
Non-European, Of these 56% of the Non-Europeans developed 
deep vein thrombosis as compared to only 47. 5% of the 
European group. This difference is not statistically 
significant (0. 25 ( P < 0. 50), although the incidence appears 
higher in the Non-European group. 
The composition of the control grrup is shown in Table VII. in 
which the majority of the Non-European patients were Cape 
Coloured (70%) , 19% were Bantu and 11% Indian. 
The mean incidence of deep vein thrombosis in these three 
groups was 56%, with 
54% in the Cape Coloured, 
50% in the Bantu and 
67% in the Indian patients. 
The small numbers did not allow statistical analysis. 
The sex distribution in the Non European patients in the three 
groups is also shown in Table VII and Figure 9. 
• 
FIGURE 8. SEX DISTRIBUTION OF POSTOPERATIVE 
DEEP VEIN THROMBOSIS IN THE GENERAL SURGERY 
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FIGURE 9 RACIAL DISTRIBUTION OF POSTOPERATIVE 
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TABLE VII RACIAL DISTRIBUTION OF CONTROL GROUP OF 












































Obesity in relationship to height , to weight for each age group. 
Three groups were analysed -
normal 
mildly obese, and 
severely obese, 
as classified by the Metropolitan Life Insurance Company 
Statistical Bulletin (166) and the Society of Actuaries (167). 
Of all the patients, 67% were normal, 14% wel'e mildly obese 
and 19% were severely obese. 
It is noted in figure 10 that 68% of the severely obese patients 
developed deep vein thrombosis as compared to 45% of the 
mildly obese and 47% of the normal patients. 
As these differences are significant severe obesity is a 
predisposing factor to development of deep vein thrombosis. 
(P < . 05). 
5. Blood Group 
Distribution of patients into blood groups ABO and Rh is 
shown in Figure 11. It would appear that Rh negative is 
more protected than Rh positive. The two patients in blood 
group AB developed venous thrombosis but the numbers are 
too small to draw any conclusions. 
FIGURE 10, OBESITY AND POSTOPERATIVE DEEP 
VEIN THROMBOSIS .. 
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FIGURE 11. BLOOD GROUP AND POSTOPERATIVE 
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II. Past History 
1. Myocardiai Infarction {diagnosed by Electrocardiograph) 
2 . Deep Vein Thrombosis 
3, Pulmonary Embolus { Chest Pain with or without Haemoptysis) 
4, Long Bone Fracture in Lower Limb 
From Table VIII it will be noted that one patient had a fracture 
of the tibia and fibula on the left side 9 years before and 
developed a deep vein thrombosis on the same side. 
One patient had a previous deep vein thrombosis diagnosed 
clinically, but remained negative, 
TABLE VIII PAST HISTORY OF CONTROL GROUP AND 
POSTOPERATIVE DEEP VEIN THROMBOSIS 
Negative Positive 
1. Myocardial Infarction 1 1 
2. Deep Vein Thrombosis 
Right 1 0 
Left 0 0 
3. Pulmonary Embolus 0 0 
4. Long bone fracture in 
lower limb 
Right 0 0 









III. Present Admission 
1. Chronic Obstructive Airways Disease 
Of 8 patients with this complication, 6 developed postoperative 
deep vein thrombosis. 
2. Oral Contraceptive Pill 
Only 2 patients were on the pill and both were negative. 
3. Varicose Veins 
Of the 10 patients with varicose veins, 9 developed deep vein 
thrombosis. Six patients had varicose veins on the right side 
and 5 developed deep vein thrombosis, 4 patients had varicose 
veins on the left side and all 4 developed deep vein thrombosis. 
This finding is significant in that pati ents with varicose veins 
have a very high risk of developing postoperative deep vein 
thrombosis. (0.01( P(0.02). See Table IX. 
4. Varicose Ulcer and Healed Varicose Ulcer 
There were no patients with varicose ulcers, but there were 3 
with healed varicose ulcers on the right side of whom 2 
developed a deep vein thrombosis on the same side. 
The presence of healed varicose ulcers usually implies 
previous deep vein thrombosis and thus perhaps a greater 
susceptibility to the development of future postoperative deep 
vein thrombosis. 
TABLE IX PRESENT ADMISSION IN CONTROL GROUP 
Negative Positive Total 
Chronic Obstructive Airways 
Disease 2 6 8 
Contraceptive Pill 2 0 2 
Varicose Veins 
Right 1 5 6 
Left 0 4 4 
Varicose Ulcer 0 0 0 
Right 0 0 0 , 
Left 0 0 0 
Healed Varicose Ulcer 
Right 1 2 3 
Left 0 0 0 
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5. Days in hospital preoperatively 
Up to the 10th day in hospital preoperatively there was no 
significant difference between the positive and negative group, 
but of the 14 patients who were in hospital 10 to 20 days before 
operation, 9 were positive. 
It seems that patients who required hospitalisation for more 
than 10 days had a greater risk of developing postope rative 
deep vein thrombosis shown in Figur e 12. 
IV. Operation 
1. Duration of Operation 
An operation lasting less than half an hour, or half to one hour 
there was no difference between the two groups (Figur e 13). 
In the series of 63 patients who had operations lasting one to 2 
hours, 35 were positive i.e. 55%. Fo r operations lasting 
two to four hours there was no difference between the 2 groups. 
(Figure 13). 
It appears that a patient undergoing an operation of any 
duration was liable to develop deep vein thrombosis, but was 
at a greater risk if the operations lasted one to two hours. 
2. Type of Operation 
The patients were grouped according to operative site as head 
and neck, breast, vascular, exploratory abd.ominal laparotomy, 
oesophagus, stomach and duodenum, smaU bowel and appendix, 
108 
large bowel, spl een , gall bladder and liver , anus and r e ctum, 
hernia and othe r. 
From Table X, it will be seen that any patient undergoing any 
type of operation was prone to d e velop deep vein thrombosis 
postoperatively. Those undergoing operations on the stomach 
and duodenum were at a slightly greater risk. Again small 
numbersrender correlation difficult. 
3. Pathology 
Patients were grouped as shown in Table XI. 
Irresectable carcinoma was associated with a higher risk as 
compared to resectable carcinoma, 65% and 33% respectively 
developed deep vein thrombosis. 
4. Operative Blood Loss 
In 13 patients, more than 3 pints of blood was given during 
operation and of these 7 were positive and 6 were negative. 
No conclusion can be drawn. 
FIGURE 12 DAYS IN HOSPITAL PREOPERATIVELY 



































FIGURE 13 . DURATION OF OPERATION AND 
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TABLE X. SITE OF OPERATION 
Negative Positive Total 
Head and Neck 4 3 7 
Breast 1 1 2 
Vascular 3 2 5 
Exploratory Laparotomy 20 23 43 
Oesophagus 0 0 0 
Stomach and Duodenum 8 15 23 
Small Bowel and 
Appendix 4 4 8 
Large Bowel 3 3 6 
Spleen 4 6 10 
Gallbladder and 
Liver 8 10 18 
Anus and Rectum 3 2 5 
Hernia 8 9 17 
Other 2 4 6 
TABLE XI OPERATIVE PATHOLOGY 
Negative Positive Total 
Congenital 0 l l 
Traumatic 11 15 26 
Inflammatory 21 21 42 
Carcinoma 20 21 41 
Resectable 12 6 ( 33%) 18 
Irresectable 8 15 (65%) 23 




The range of postoperative complications is shown in Table XII. 
No correlation is noted with any specific complication. 
l. Postoperative days in hospital 
From Figure 14, 
it is apparent that patients staying more than 21 days in 
hospital were at a much higher risk than patients staying less 
than 21 days. Of the 1 7 patients in hospital for more than 
21 days, 14 developed deep vein thrombosis , (an incidence of 
80%). In this group over 75% of the venous thromboses 
developed within the first 72 hours •. 
The patients either had severe gross pathology preoperatively 
or underwent major surgery necessitating prolonged postoperative 
care. These factors may have precipitated the early 
development of deep vein thrombosis. 
3. Postoperative Deaths 
From Figure 15 it would appear that patients dying after the 
21st postoperative day were more likely to develop deep vein 
thrombosis than any other group. Three out of the 4 patients 
who died after the 21st day developed deep vein thrombosis 
which was detected early postoperatively. The aetiological 
factor for the increased incidence of deep vein thrombosis 
in these patients dying is probably the same as above viz. 
major pathology and surgery including postoperative morbidity. 
• 
TABLE XII POSTOPERATIVE COMPLICATIONS 
Negative Positive Total 
Pulmonary 12 15 37 
Urinary 7 6 13 
Wound Infection 3 4 7 
Wound Dehiscence 0 1 1 
Miscellaneous 4 3 7 
FIGURE 14. POSTOPERATIVE DAYS IN HOSPITAL 
TILL DISCHARGE AND INCIDENCE OF POSTOPERATIVE 
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Recent studies have shown that there is a High Risk Group of 
patients liable to develop postoperative deep vein thrombosis 
(1, 4, 7, 23, 26, 168). 
The factors which appear to be important are patients over the 
age of 40 years {2 3) or elderly (28), undergoing a major 
surgical operation ( 168), who have had a past history of deep 
vein thrombosis or pulmonary embolism {28, 168), have 
varicose veins {168) and found to have c arcinoma at operation 
{28, 168, 170). 
Browse (26) considers patients undergoing a splenectomy or 
with certain blood disorders as polyc ythaemia predispose to 
venous thrombosis. For purposes of this discussion, 
orthopaedic cases which comprise a high risk group, have 
been excluded {23,152). 
Preoperative and postoperative assessment of the high risk patients 
is important, for it is this very group who should be screened 
with radioactive fibrinogen and Doppler ultrasound and be treated by 
suitable PROPHYLACTIC means to prevent the deep v ein 
thrombosis. 
In an analysis of High Risk Factors, in this study, several 
facts have emerged. Patients in the a) age group of over 40 
years, especially if b) severely obese were at high risk . 
c) 'l\ose showing evidence of varicos e veins and healed varicose 
ulcer seemed susceptible. d) Patients admitted for investigations 
preoperatively or transferred from the medi cal wards where 
they had been investigated for more than 10 days were at an 
increased risk. e) Any operation requiring a general anaesthetic 
lasting longer than one to two hours e specially if the patient had 
f) an irresectable carcinoma,was also of importance. 
1 2 2 
c. CONCLUSION 
A number of conditions in the patient, his history, the
 
operation or the postoperative course may influence th
e 
development of deep vein thrombosis . 
An awareness of these should lead to prophylaxis and e
arlier 
treatment. 
1 2 3 
B. THE DIAGNOSIS OF POSTOPERATIVE DEEP VEIN THROM
BOSIS 
• 
1. ONSET OF POSTOPERATIVE DEEP VEIN THROMBOSIS 
2 .. RADIOACTIVE FIBRINOGEN TECHNIQUE 
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1. ONSET OF POSTOPERATIVE DEEP VEIN THROMBOSIS 
a. In ~.r o c1 uction 
b. Results 
c. Discussion and Conclusion 
a. Introduction 
Recent studies by Kakkar (26) and Negus {8) suggest that deep 
vein thrombosis occurs much earlier than is suggested by 
standard texts. 
In fact, that the thrombi start to form while the patient is on the 
operating table or within the next 48 to 72 hours. 
The 130 cases under review were studied for the time of onset 
of the deep vein thrombosis. 
b. Results 
The incidence of postoperative de e p vein thrombosis in the 
General Surgical Wards at Groote Schuur Hospital in 130 cases 
was Slo/o. 
The diagnosis was made by a combination of clinical assessment, 
the radioactive fibrinogen technique, Doppler ultrasound 
technique and venography. 
From Figure 16 it will be seen that 50% of the cases developed 
deep vein thrombosis within the first day postoperatively and a 
further 26% developed deep vein thrombosis between the second 
and third day postoperatively. Therefore, 76% of the 
postoperative deep vein thromboses occurred within the first 
48 to 72 hours postoperatively. Only 6. 5% developed 
deep vein thrombosis on the 7th - 10th day postoperatively 
and there were no cases recorded after the 10th postoperative 
day. 
1 2 5 
All cases were screened with radioactive fibrinog en, p reoperatively 
and counting was continued daily postopera tively. In a large 
percentage of cases (75%) there were increased counts at points 
over the lower limb which were not as yet diagnostic of a deep 
v ein thrombosis i.e. had not yet increased by 20%, but over the 
subsequent days the level of radioactivity increased at those 
sites to diagnostic levels as defined by Negus (8), Kakkar (26) 
and Browse (28). 
In 40 cases who were screened within 1 to 2 hours postoperatively 
i.e. immediately on returning to the ward from theatre, it was 
found that 10% of these cases had evidence of deep vein thrombosis 
in the calf as detected by the radioactive fibrinogen technx:i_ue. 
c. Discussion and Conclusion 
The early onset of deep vein thrombosis is of the utmost importance 
in its prevention as measures must b egin interoperatively and even 
preoperatively and must continue postoperatively. 
Our results confirm that venous thrombosis begins on the operating 
table or Wl thin the first 48 to 72 hoi.rs postoperatively as was 
shown in 76% of the cases. 
FIGURE 16. ONSET OF POSTOPERATIVE DEEP 
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2. RADIOACTIVE FIBRINOGEN TECHNIQUE 












fibrinogen was used to screen patients for deep vein 
thrombosis, recognizing that its accuracy was probably limited 
to calf and lower thigh. 
b. Results 
Incidenc e 
Sixty-Six of 130 control cases were positive giving an incidence 
of 51%. 
Ons et 
The ons et of the deep vein thrombosis occurred in 50% of the 
cases within the first postoperative day a nd in a further 26% 
of cases between the second and third postoperative day. 
(Sec Figure 16) 
1 2 9 
Side 
Out of 66 patients, 42 developed bilateral deep vein thrombosis (64%) 
D eep vein thrombosis occurred twice as commonly on the right 
side as on the left side. (See Table XIII). 
Site 
The different sites were analysed .at which the deep vein thrombosis 
occurred. The sites were subdivided into 1) calf, 2) popliteal, 
3) thigh, 4) calf and popliteal, 5) calf, popliteal and thigh, 
6) popliteal and thigh and 7) calf and thigh. (See Table XIV) 
Deep vein thrombosis in the calf alone, occurred in 43% of cases. 
In the popliteal vein or popliteal and calf veins, deep vein 
thrombosis occurred in 33% and in the thigh alone or in 
combination in 24%. Thus in the Ilio -Femoro-Popliteal 
veins the incidence of deep vein thrombosis was 57%. 
Duration 
Duration of radioactive fibrinogen counting (Fig. 17). It is 
noted that at 7 to 10 days, 44% of cases with positive readings 
were still r egistermg counts as compared with 27% of the 




SIDE OF DEEP VEIN THROMBOSIS IN 66 GENERAL SURGERY 
CASES DIAGNOSED BY 1125 FIBRINOGEN TEST 
Bilateral in 42 cases 64% 
Unilateral in 24 cases 36% 
Right 16 24% 











S I T E OF DEEP VEIN THROMBOSIS IN 66 GENERAL CASES 
(AS A PERCENTAGE) 
DIAGNOSED BY I125 FIBRINOGEN TEST 
% Right % Left % Total 
Calf 46 40 43 
Popliteal 14 8 11 
Thigh 2 2 2 
Calf and 
Popliteal 19 23 21 
Calf and 
Popliteal and 
Thigh 12 17 14.5 
Popliteal and 
Thigh 3. 5 2 3% 
C a lf and Thigh 3. 5 8 6% 
FIGURE 17. DURATION OF RADIOACTNE FIBRINOGEN 
COUNTING IN 130 GENE RA L SURGERY CASES 
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c. Discussion 
Deep ve in thrombosis may be considered to occur 1n 
1. The peripheral or calf or lower segment, and 
2. The thigh or ilia-femoral or upper segment 
including popliteal veins. 
1. Calf deep vein thrombosis accounts for the majority 
(80 to 90%) as reported by Negus (8) and Kakkar (26). 
One third occur on the left side, one third occur on the 
right side, and one third bilaterally (26). 
In this series, only 43% of the postoperative deep vein 
thrombosis occurred in the calf alone. Sixty-four percent 
were bilateral and the right side was twice as commonly 
involved as the left. As shown by the duration of the 
radioactive fibrinogen counting in the fig. 17 the thrombi 
persisted in the veins for up to three weeks and did not undergo 
spontaneous thrombolysis within several days as has been 
reported (171). The fall- off of radioactive fibrinogen 
counting must be seen as predominantly due to the short 
half-like of the radioactive r125 and the degradation of the 
fibrin ogen by the body. This therefore does not necessarily 
mean that the clot underwent spontaneous thrombolysis. 
In fact, the thrombus could have remained in situ for weeks 
to months during which period it could have extended and 
embolised. 
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Th e n a tur a l history o f the d eep vein thrombo s i s is m t he m ajority 
of cases to under g o spontaneous throm bolysis . S m a ll percentage 
will und e rgo r ecanalisation w ith r esulting incomp e tent p e rforator 
veins and the long term morbidity of venous hypertensim (174). 
Approximately 10% to 25% (172,173) extend into the popl:i.teal 
and ilio - femoral ve i ns. In this group of extension, 50% to 70% 
will have pulmonary emboli which are usually small and not 
very serious, but may be multiple and large resulting in 
considerable morbidity and mortalit y . (172,173,175). 
2. Ilio-Femoral Venous Thrombosis 
occurs in the minority of cases. Kakkar (26) reported an 
incidence of 1 O. 5% diagnosed b y radioactive fibrinogen technique. 
The thrombosis may be localised to the iliac, femoral or 
pop liteal vein or can be extensive, it may be occlusive or non-
occlusive, unilateral or bilateral, consecutive or non-consecutive 
and multifocal (50,173). 
It has been stated that the left common iliac vein is more 
commonly involved than the right side in proportion of 3 : 1, 
but if pulmonary emboli are present, the right side is more 
often inv olved than the left side (173). Mavor in his series 
of 260 cases found that pulmonary emboli occurred in 50% 
of the patients and that pulmonary emboli were the presenting 
symptom in 50% of these c ases (173). Ilio-femoral venous 
thrombosis c a rries a rnortality of 30% du e to pulmonary 
emboli (176, 177) and a c oncomitant sev ere morbidity due 
both to the local thrombosis and due t o recurrent pulmonary 
embolism . The morbidity must be assessed in the acute 
phase and in the chronic long term results (173). From the 
results presented it is important to note that the popliteal 
vein was involved either alone or in c ombination in 33% of 
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c;ases and the femoral vein was involved alone or in combination 
in 24% of cases making a total of 57% involvement of the 
femoro-popliteal venous system. This is a much higher 
figure than has been recorded previously {26). 
It must also be observed from the results that the veins 
can be involved in a multi-focal distribution e.g. the calf 
on one side, and the thigh on the opposite side, or calf and 
thigh on one side and popliteal on opposite side ie. various 
c ombinations of venous involvement { Table XIV) 
d. Con cl us ion 
A much higher incidence of involvement of the femoro-popliteal 
venous system has been found on screening with radioactive 
fibrinogen than has been previously recorded. Two fifths 
of the deep vein thromboses occurred in the calf whereas 
three fifths occurred in the femoro-popliteal region. 
The popliteal vein belongs to the high or ilio-femoral deep 
vein thrombosis group in regard to morbidity and mortality. 
The clots can be local or extensive, consecutive or non-
consecutive, bilateral in two thirds of the patients and unilateral 
in one third with the right side being more common ly involved 
than the left side and the clots can occur in a multi-focal 
distribution. The radioactive fibrino g en technique is 
however not reliable in the upper one third of the thigh due 
to the increased blood flow in this area and therefore a 
combination of ultrasound, radioa c tive fibrinogen and 
venography has been used for the diagnosis of venous 
thrombosis in this a rea. 
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3. DOPPLER ULTRASOUND TECHNIQUE 
a. Introduction 
b. Results 
c. Discussion and Conclusion 
a. Introduction 
Doppler ultrasound was used for the diagnosis of popliteal 
and ilio -femoral venous thrombosis. The investigation 
was carried out preoperatively and performed daily 
postoperatively and "all or none" principle was used 1n that 
either a sound was pre sent which indicated a patent vein 
or a sound was absent on either calf or thigh compression 
which indicated venous obstruction. 
The probe was placed over the femoral vein and compression 
was applied firstly to the calf and then to the thigh. The 
probe was then moved to the popliteal fossa and calf compression 
was applied. With the probe over the femoral veins, the 
patient was requested to perform a Valsalva mano e uvre and 
an augmentation sound was listened for indicating patency 
of the iliac veins and inferior vena cava. 
b. Results 
Seventy-five patients were screened using Doppler ultrasound 
a nd radioactive fibrinogen. Thirty-nine cases were positive 
by Doppl er ultrasound testing giving postoperative incidence 
of de e p vein thrombosis o f 52%. There were no cases of 
false positive r esults. However, 6 of 39 cases gave false 
negati ve results. All these cases had thrombosis of the calf with 
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no extension into the popliteal vein. In 39 positive c a s es, 
24 were bilateral (62%) and 20% oc curred on the right s ide 
with 18% on the left. 
c . Discussion and Conclusion 
Doppler ultrasound has a place in the screening of postoperative 
deep vein thrombosis for the detection of thrombi in the 
popliteal and ilio-femoral veins. It is unreliable for the 
detection of small thrombi in calf muscles (34, 37). 
In the partially occluded vein where there is still blood flow 
through the lumen, it is theoretically unreliable (36). 
However, in this series there were no false negative results, 
in this regard. In long standing cases of venous thrombosis 
with the development of adequate collateral circulation 
Doppler ultrasound is only reliable in 80% of cases (36). 
It is thus of limited value in the isolated single screening of 
a patient thought to have a silent ''pulm onary embolus''. 
In the patient who present with a swollen leg or other evidence 
of deep vein thrombosis, if the Doppler ultrasound is positive 
indic ating obstruction of the major veins, it is extremely reliable 
(35). Howeve r , if negative, indic ating flow beneath the 
probe, this c ould mean a partial occlusion of the v eins or a long 
standing occlusion with development of adequate collateral 
venous circulation. In order to make a definitive diagnosis 
venography is indicated. 
Doppler ultrasound has a useful place in the screening of 
patients to detect development of deep vein thrombosis provided 
that a baseline is obtained preoperatively and that the patient 
is screened daily postoperatively in search of an alteration in 
venous blood flow. As an isolated invesbgation, if positive, 
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it may be diagno s ::i c but if negative it does not exclude deep 
vein thrombosis. 
The disadvantages of the procedure relate especially to the 
high false negative results, if the c a lf veins alone are 
involved and the inability to detect t h rombi in the pelvic veins. 
There may be difficulty in interpret.mg results of Valsalva manoeuvre 
for patency of the inferior vena cava and iliac veins because 
patients may be unable to sit up and perform the Valsalva 
manoeuvre adequately immediately after abdominal operation. 
Overall, the ultrasound procedure is very suitable for mass 
application screening and surveillance provided its limitations 
are borne in mind (31), and for routine use in a General 
Hospital (38 ). The advantages of the procedure include 
safety, simplicity and economy acceptable to both physician 
and patient. Examination can be performed on a traumatised 
extremity, takes only a few minutes and there is no delay 
between examination and results. 
4. VENOGRAPH Y 
a. Introduction 
b. Results 
c . Discussion 
d. Con c lusion 
a. Introdu c tion 
Venography was not performed routinely, but was employed 
to confirm the screening methods and then later used only 
m sele c ted patients for specifi c reasons. The evaluation 
of a screening surveillance procedure is best expressed 
• 
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m terms of sensitivity and specificity compared to more definite 
definitive final outcome (36). 
Sensitivity is defined as the number of positive extremities 
obtained divided by the actual number of extremities proved 
to have venous occlusion by venography or anatomical 
confirmation. Specificity is defined as the number of negative 
extremities observed, divided by the number of extremities 
proven to be non-occluded. Both sensitivity and specificity 
are expressed as percentages (36,178). 
b) Results. 
A total of 32 patients m the control group underwent peripheral 
venography of the lower limb. The technique used was a 
percutaneous injection of contrast medium into the veins of 
the feet using the standard method described by Lea Thomas 
(50-54). A total of 60 lower extremities were examined. 
The sensitivity which is defined as above was l 06% by 
venography. See Table XV . 
TABLE XV SENSITIVITY OF RADIOACTIVE 
FIBRINOGEN IN DETECTING 
DEEP VEIN OC CLUSION 
Number of extremities found occluded by venography 






The specificity defined as above was 92%. See Table XV I . 
TABLE XV I. SPECIFICITY OF RADIOACTIVE FIBRINOGEN 
IN DETECTING DEEP VEIN THROMBOSIS 
Number of extremities found non-o c cluded by venography 12 





When the investigation into the incidence of postoperative 
deep vein thrombosis was begun, radioactive fibrinogen 
and Doppler ultrasound were used for screening. 
If a deep vein thrombosis was shown, venography was 
performed to confirm the diagnosis. However, after 32 
patients had been examined by venography and the correlation 
of venography versus the screening proc!edures was found 
to be accurate, it was felt not justifiable to submit e very 
positive patient with a deep vein thrombosis to venography. 
Thereafter venography was performed in patients who had 
failed to respond to anticoagulant therapy or in those in 
whom surgery was contemplated or if there was any other 
specific indication, e.g. unable to carry out screening 
procedures. Venography was thus not used merely to 
confirm the diagnosis, but was carried out only in selected 
patients. In three patients deep vein thrombosis was 
demonstrated by radioactive fibrinogen but not by venography, 
probably due to the presence of small thrombi in the calf 
muscle venous plexus which could not be adequately demonstrated 
by venography. Thus radioactive fibrinogen is pr ob ably a 
more sens:itive method of demonstratin g small thrombi in the 
soleal plexus of veins than venography. 
Interpretation 
Interpretation of venograms depends on identification of a 
thrombus as a cylindrical or roun d translucency in an 
opacified vein. A completely occluded vein may be totally 
blocked or bypassed by collaterals. Common causes for 
a rtefacts were underfilling, dilution or streamlining of the dye. (50) 
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Advantages 
Venog r aphy can demonstrate the veins from the ankl e to the 
inferior vena cava. It gives an indication of the size and 
extent of the thrombus, and the fixity or loose adherence to 
the vein wall. In one case a loose thrombus was blocked m 
by a more proximal adherent thrombus and was therefore 
unable to embolise. The main limitation of venography is 
that some clinical indication for its use is ne c essary and 
only too often thrombosis occurs without physical signs. 
Thus it had value in the diagnosis of a suspected case, 
but was of no use as a screening or a research tool. 
The procedure took an average of 30 minutes to perform 
bilateral lower limb venography. In no cases was it found 
necessary to perform a percutaneous transfemoral venogram 
nor a pertrochanteric injection. 
With improved expertise the iliac veins were demonstrated 
in most .cases and with adequate p a tien t co-operation in seven 
cases the inferior vena c ava was de :monstrated. 
Complications 
It has been reported by Lea Thomas (50-54) that peripheral 
venography can be carried out without signific ant complication, 
but several possibilities exist and some were encountered 
1n this series. 
1. Thrombosis due to the contrast medium 
After the use of the c ontrast medium Conray 280 (Meglumine 
Iothalamate 60%) followed at the end of the procedure by the 
veins being thoroughly cleared with norm a l saline. There 
we re n o thrombo s es in this series as a re s u lt of c on t rast used. 
• 
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2. Local sepsis 
This m ay occur at the site o f puncture a n d therefore c areful 
aseptic precautions are necessary. It is especially important 
to avoid sepsis in those patients with impaired vascular supply 
to the lower limb. This complication occurred in four of the 
60 lower limbs examined in this series (an incidence of 15%). 
Streptococci were grown in two cases and the other two cases 
were thought to be local allergic response to the extravasation 
of dye into the subcutaneous tis sues. One occurred in a 
patient with severe peripheral vascular disease and the 
resultant necrotic ulcer took three months to heal. It 
was thus felt that venography should not be performed in any 
patients showing severe peripheral vascular disease unless 
there was an absolute indication. Under these conditions 
a transfemoral percutaneous venogram should preferably be 
performed. Intraosseous pertrochanteric venography 
carries a risk of osteomyelitis, and no such procedure was 
undertaken in this series. 
3. Precipitation of pulmonary embolism 
The use of Valsalva maneouvre and the use of calf pressure 
has been criticised as likely to precipitate pulmonary embolism. 
This complication has not been reported (50) and no obvious 
cases of pulmonary embolism develop e d in this series. 
4. Pain 
Lea Thomas (50) states that the c ontr a st medium (Meglumine 
Iothalamate) injection is painless when administered and 
produces little discomfort to the patient apart from a bursting 
sensation in an obstructed venous system. 
• 
l 4 6 
However, on special interrogation o v er 50% of our patients 
c o mplained o f an unpleasant burning s ensation a s sociated with 
pain on injection of the contrast medium. Premedication 
such as Omnopon and Valium was thus routinely prescribed 
before the procedure. 
5, Drug allergy and hypersensitivity. 
The relatively large quantity of contrast medium which may be 
necessary (up to 400 ml) to show the veins of both legs and 
pelvis has not resulted in any complications and appears to be 
entirely safe. This is confirmed by others (50). 
6. Gangrene 
Lea Thomas (52) reports two out of 400 patients who developed 
gangrene of the foot following peripheral venography. In 
these patients there was evidence o f malformation or thrombosis 
of the deep venous system which prevented the contrast medium 
from escaping readily from the site of injection. This suggests 
that if deep venous filling does not occur, examination should be 
abandoned and may be later repeated by an intraosseous 
injection of contrast medium into the medial malleolus, 
d. Conclusion 
Thirty-two patients have undergone venography and a total of 60 lower 
limbs have been examined. The advantages are the demonstration 
of veins from the ankle to inferior vena cava and confirmation of the 
diagnosis of venous thrombosis in all cases in which it was carried 
out. Investigation js not however reliable for demonstrating small 
thrombi in the calf muscle veins. 
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It seems that the investigation does have complications and 
therefore m ust not be carried out as a rout ine in a ll patients 
suspected of or found to have deep vein thrombosis on screening 
with radioactive fibrinogen and Doppler ulatrasound. Venography 
should be reserved for those patients in whom thrombolytic 
therapy or surgical tre a tment such as thrombectomy and venous 
ligation are being contemplated. 
5. CLINICAL ASSESSMENT IN THE DIAGNOSIS OF POSTOPERATIVE 
DEEP VEIN THROMBOSIS 
a. Introduction 
b. Results and Discussion 
c. Con c lusion 
a. Introduction 
Until the development of the aforemention ed techniques, clinical 
assessment was the only m e thod of diagnosis of postoperative deep 
vein thrombosis. 
With the advent of the new techniques the inaccuracy of clinical 
signs has become evident. 




The classical signs of deep vein thrombosi s were looked for in 
all cases . 
detected. 
In only 6 cases was deep vein thrombosis clinically 
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Signs found :-
1, Swelling of calf in 5. Severe m 2 and minimal m 3. 
2. Oedema of calf in 4. 
3. Tenderness over popliteal and femoral vein m one. 
4. Homan~s... sign in O. 
Five out of the six clinically detected deep vein thromboses 
were found to have positive radioactive fibrinogen and Doppler 
ultrasound findings. One patient who had a clinical deep vein 
thrombosis on the right side, which was not confirmed on 
fibrinogen, had an asymptomatic venous thrombosis on the left 
side. The overall incidence of clinically detected and 
confirmed deep vein thrombosis was 7. 5%. 
2. Symptoms 
Thirty-eight patients were questioned about the development of 
pain in the calf. This was carried out retrospectively once the 
deep vein thrombosis had been diagnosed by the screening methods. 
Ten out of the 38 cases mentioned that they had experienced pain 
in the calf postoperatively but in the majority it was not severe 
enough to report to the medical attendant, Furthermore the pain 
had developed in the calf after the first 5 days postoperatively. 
Discussion: 
''Silent' 1 pulmonary emboli repeatedly s bowed the inadequacy of 
physical signs and symptoms in the diagnosis of lower limb deep 
vein thrombosis. Not only is deep vein thrombosis often overlooked, 
but it is also frequently diagnosed where none is present ( 10). 
Lambie (7) studied a group of 111 surgical patients at high risk 
and found that two thirds of those developing deep vein thrombosis 
were never suspected clinically, despite careful assessment. 
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In tho s e in whom a clinical diagnosis of thigh and leg venous 
thrombosi s was 1n a d e , this diagnosis w a s fals e ly positive in 
one quarter. It thus appears that close and repeate d clinical 
eva luation is highly unreliable and little importance should be 
s e t by it. It is better to be conscious of the large number of 
patients who have thigh and leg venous thrombosis despite the 
apparent normality of their legs. 
Lambie et al ( 7) results showed that 
Calf tenderness was present i n 6/61 legs with thrombosis 
and 5/161 legs without thrombosis~ 
Homan' s sign was positive in 14/ 61 legs with thrombosis 
and 2/161 legs without thrombosis. 
Ankle oedema was present in 18/61 limbs with thrombosis 
and in 3/ 161 limbs without thrombosis. 
Fever was noted in 14/49 patients with thrombosis and 
30/62 patients without thrombosis. 
From the results at Groote Schuur Hospital only 7. 5% patients with deep 
vein thrombosis had classic al signs of deep vein thrombosis and in one 
patient there was a false positive result. However, the symptom of 
pain in the calf was present in 26% of the patients found to have venous 
thrombosis. 
It was th e n decided to investigate the sign of tenderness over the 
poplitc al and femoral vein in patients clinically suspected of having 
deep v e in thrombosis as seen in consultation with other wards. 
Results showed that in 9 patients with ilia -fe moral-popliteal 
v e n o us thrombosis confirmed by Doppl e r ultrasound and v e nogr ;tph y , 
all had tend e rn e ss in o n e o r more sites ov e r the fe m o r a l and 
popliteal v e in s , whi c h could be detected by ca reful digi t al palpation. 
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C. Conclusion 
Classical clinical signs of deep vein thrombosis were present 
in less than 10% of patients found to have venous thrombosis. 
However, local tenderness over the popliteal or femoral vein 
if present, appears to be an extremely reliable physical sign 
of an underlying venous thrombosis. The symptom of pain 
in the calf must be carefully sought daily and should it be 
present, an underlying venous thrombosis must be suspected 
despite the absence of signs. The symptom of pain therefore 
warrants further investigation rather than the signs of venous 
thrombosis. 
• 
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6. CONCLUSION ON ASSESSMENT OF TECHNIQUES FOR THE 
DIAGNOSIS OF POSTOPERATIVE DEEP VEIN THROMBOSIS 
Conclusion 
1. Clinical detection 
a. Signs - 7. 5% 
b. Symptoms - 26% 
2. Radioactive fibrinogen 66/66 = 100% 
3. Ultrasound 33/39 = 85% 
4. Venography 48/ 51 = 94% 
It has been shown that a combination o f daily postoperative 
screening of patients with radioactive fibrinogen and Doppler 
ultrasound gave a highly reliable method of the detection of 
postoperative deep vein thrombosis. Venograph y was re served 
for sele c ted cases only. The clinical detecti on of d e ep vein 
thrombosis by physical signs was extremely unreliable but the 
symptoms of pain was found to warrant further investigation 
in unscreened patients. 
INCIDENCE m 
Introduction 
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NEUROSURGERY 
OPHTHALMOLOGY AND OTORHINOLARYNGOLOGY 
POST RENAL TRANSPLANTATION 
A survey was conducted into the incidence of deep vein thrombosis 
in patients undergoing different forms of operation. 
Neurosurgery because of no previous reports in the 
literature, procedures with minimal operative tissue trauma 
as in ophthalmology and otorhinolaryngology and post renal 
transplantation as a result of late thromboembolic disease 
which was fatal in two patients at Groote Schuur Hospital. 
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INCIDENCE 
2. NEUROSURGICAL CASES 
a. Results 
b. Discuss ion 
c. Conclusion. 
a. Results 
Twenty three patients were screened for postoperative deep 
vein thrombosis using radioactive fibrinogen and Doppler 
ultrasound. See Table XVII. 
Assessment of 
i. Age distribution 
The patients undergoing spinal operations who were 
positive, were predominantly in the lower age group. 
ii. Sex Distribution 
This was evenly distributed in the craniotomy but there was 
a male preponderance in patients positive after spinal 
ope rations. 
iii. Obesity 
Two of the 6 positive spinal cases were severely obese and 
the one patient had bilateral varicose veins with a past history 
of deep vein thrombosis. 
iv. Days in hospital preoperatively 
The re appeared to be no difference in the two groups, but 
there were too few patients for an adequate comparison. 
TABLE XVII. INCIDENCE OF POSTOPERATIVE DEEP 
VEIN THROMBOSIS IN NEUROSURGERY 
Total 23 patients - 10 positive = 43% 
Spinal 10 patients - 6 positive = 60% 
Cranial 13 patients - 4 positive = 39% 
• 
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v. Race 
Ele ven of the patients were European and 12 Non-European. 
Sixty-six percent of the Europeans developed deep vein thrombosis 
whereas only 25% of the Non-fil_lropeans developed postoperativ e 
deep vein thrombosis which is significant (0. 05 ( P < 0.1). 
The ratio. of European to Non-European developing postoperative 
deep vein thrombosis in those undergoing craniotomy was 3 : 1 
and those undergoing spinal operation 2 : 1 respectively. 
vi. Type of Operation (See Table XVII and Figur P 18) 
The operations were subdivided into spinal in which 60% were 
positive and craniotomy in which 39% were positive (0.1 ( P( 0.2) 
b. Discussion 
The literature contains .little information about the postoperative 
incidence of deep vein thrombosis in neurosurgical patients. 
The overall incidence is presumed to be low because of the early 
m0vement and mobilisation of these patients. However, in 
acute paraplegia following spinal injury a major cause of death 
is pulmonary embolism. Walsh and Tribe (179) in 1965 found 
that of 500 cases of traumatic spinal injury admitted at the 
Stoke Mandeville Hospital, 15 died of pulmonary emboli. 
Chesire (180) in a group of 315 admissions had two deaths from 
pulmonary emboli. Watson (181), in 1968 found that amongst 
413 similar admissions over a 10 year period, there were 
7 deaths from pulmonary emboli and a furtre r 15 patients 
were diagnosed clinically as having this condition although 
they recovered. 
Silver and Moulton found 6 pulmonary emboli in 42 patients 
with ac ute traumatic paraplegia with 2 being fatal. Clinical 
deep vein thrombosis was present in 6, half of which developed 
pulmonary emboli (1 82). 
FIGURE 18 POSTOPERATIVE INCIDENCE OF DEEP VEIN 
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Warlow (183) studied 30 patients with recent cerebra-vascular 
accident resulting in a stroke, for evidence of deep vein thrombosis 
using radioactive labelled fibrinogen technique. Sixty percent 
developed deep vein thrombosis in their paralysed leg and 7% 
in addition had a thrombus in the non paralysed leg. Four 
of their patients developed pulmonary embolism and two died 
of this complication at a stage when improvement in the disability 
of the stroke itself could not have been expected. The clinical 
signs of deep vein thrombosis could be detected in 60% of their 
cases with a positive fibrinogen count. 
In the results presented only one patient had obvious clinical 
evidence of a deep vein thrombosis. The one patient who had 
a laminotomy did not develop a deep vein thrombosis. It 
would appear therefore that patients undergoing spinal operation 
such as laminectomy which necessitates prolonged bed rest 
despite being turned at two hourly intervals are more likely 
to develop postoperative deep vein thrombosis. 
c . Conclusion 
It has been demonstrated that postoperative deep vein thrombosis 
in the neurosurgical wards is a real problem and has an overall 
incidence of 43%. Those patients undergoing spinal operations 
we re nearly twice as likely to develop this complication as 
those patients undergoing craniotomy. The re was one 
postoperative death, but no postmortem was performed. 
Deep vein thrombosis and pulmonary emboli have been found 
to result in considerable morbidity and mortality in the traumatic 
paraplegic patient and in those patients following cerebra-vascular 
accident. Thus it must be presumed that such a situation exists 
in the postoperative neurosurgical patients. 
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3. INCIDENCE OF POSTOPERATIVE DEEP VEIN THROMBOSIS 






Twenty two cases from the ophthalmology unit undergoing lens 
extraction under general anaesthetic for cataracts were screened 
using the radioactive fibrinogen and Doppler ultrasound. 
Only one out of 22 patients developed postoperative deep vein 
thrombosis in both calves on the 8th postoperative day. i.e. 
an incidence of 4. 5%. This patient fell into the high risk group 
in that she was 76 years old and very obese. 
was no evidence of a deep vein thrombosis. 
Clinically there 
Nine patients from the otolaryngology wards were screened for 
postoperative deep vein thrombosis. They all underwent an 
operative procedure under genera 1 anaesthetic lasting more than 
30 minutes. Only one of the patients was positive and she 
developed bilateral calf deep vein thrombosis on the first 
postoperative day. She was a very obese Non-European female, 
aged 53 years who underwent a Caldwell-Luc operation for a 
pathological diagnosis of a plasmacytoma of the upper alveolus. 
Clinically, there was no evidence of a deep vein thrombosis. 
b. Discussion 
Becaus~ of the high incidence of de ep vein thrombosis in the general 
8urg e ry \.\·ard8, it was felt necessary to investigate the 
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incidence occurring m those patients undergoing rela tive l y m inor 
operative trauma e.g. lens e xt r ac t ion, b u t r e quiring a g en e r a l 
anaesthetic, a procedure lasting ! to 1 hour and postoperative 
inpatient hospital stay of more than 3 days. 
Those patients undergoing ophthalmological and otolaryngological 
procedures appeared to be the ideal patients to study. 
Our results of 4. 5% and 11 % respectively with a n overall 
incidence of 6% in these 31 patients studied illustrated that 
postoperative deep vein thrombosis and its sequelae were not of 
considerable importance in these cir c u m stances. It would 
however appear that the very obese patients w e re the most 
likely to be at risk and therefore a lens extraction might be 
performed under local anaesthetic in the high risk patient. 
Patients in both units were actively mobilised early postoperatively 
and underwent minimal operative tis sue damage. These two 
factors alone might be important in the aetiology of deep vein 
thrombosis. 
c. Conclusion 
A very low incidence of postoperative deep vein thrombosis 
was found in the ophthalmology and otola ryngology wards. 
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4. INCIDENCE OF POSTOPERATIVE DEEP VEIN THROMBOSIS 
AFTER RENAL TRANSPLANTATION 
a. Results 
b . Discussion 
c. Conclusion 
a. Results 
Seven patients who underwent renal transplantation were screened 
with radioactive fibrinogen and Doppler ultrasound. Four of 
these developed postoperative deep vein thrombosis (57%). 
One patient showed obvious clinical evidence of deep vein 
thrombosis and a second patient had equivocal clinical signs. 
Five patients were European, 2 were Non-European, 4 were 
Mal e and 3 Female, and only one patient was severely obese. 
All patients were admitted within 24 hours preoperatively and 
duration of the operation was from 2 to 4 hours. 
Venography was performed in only one patient and this showed 
patency of the major deep venous system bilaterally . 
One patient developed clinical and radiological lung changes 
compatible with a pulmonary embolus and was treated with 
anticoagulants. 
The onset of the postoperative deep vein thrombosis was on 
the 9, 11, 12 and 14th postoperative days . The duration of 
counting in two cases was two weeks and for 5 cases continued 




Of the 4 patients who developed postoperative deep vein 
thrombosis, two had their transplanted kidneys on the right side 
and two on the left side. However, in two cases the deep vein 
thrombosis developed bilaterally with extension into popliteal 
and femoral veins. One unilateral positive was on the same side 
as the transplanted kidney. 
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Two further patients underwent nephrectomy, one bila t e r a l in a girl 
of 14, who did not develop a deep vein thrombosis and the other 
for graft rejection who developed a calf venous thrombosis. 
b. Discussion 
Postoperative deep vein thrombosis occurred in patients undergoing 
renal transplantation but appeared to be unrelated to the side 
upon which the transplanted kidney w a s inserted. The venous 
thrombosis developed only in the second to third postoperative 
week. In an analysis of reasons for the late development, the 
most obvious cause was that following renal transplantation the 
patients usually had renal dialysis every second day. The 
machine was pri::ned with heparin as the anticoagulant. 
This probably acted as an effective prophylactic measure in the 
early postoperative period. Once the patient began passing 
urine spontaneously and haemodialysis was discontinued the 
deep vein thrombosis developed late. 
A further interesting finding was the period of time that the 
radioactive labelled fibrinogen stayed in circulation and could be 
measured. There is no known explanation for this at present. 
In regard to the negative venogram in the one patient, it must be 
presumed that the venous thrombosis occurred either in the 
superficial veins or the small venous plexuses in the muscles of 
both the calf and the thigh which were not demonstrated by 
venography. 
Starzl (184) in 1964 reported that 9 out of 4 2 patients following renal 
transplantation developed thrombophlebitis and five probably had 
pulmonary emboli. The conditions which predisposed to this high 
incidence of deep vein thrombosis, and also the lengthy manipulations 
of veins within the pelvis, could also be e xpected to predispose 
to thrombosis of the transplanted renal vein, yet there are few 
references to renal vein thrombosis as a complication of transplantation. 
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Clarke (185) reports one case in whi ch th e renal v ein gr aft was 
o c cluded by thr o m bus ascending fr o m the v enous thrombosis 
of the leg. 
A retrospective analysis was made at Groote Schuur Hospital 
over a five year period (1967 to 1972) in which 47 renal transplants 
were performed in 43 patients. Of the 15 patients who died, 
there were at least two deaths due t o pulmonary emboli. 
However it was not noted what p e r centage had deep vein 
thrombosis. 
c. Conclusion 
Deep vein thrombosis and its sequelae following renal 
transplantation carries severe morbidi ty and possible mortality 
in an already ill patient. Such patients usually have a 
combination of severe postoperative complications following 
transplantation. They often require multiple operations 
and they can ill afford to have the added problems of thrombo-
embolic disease. 













Due to the high incidence of deep vein thrombosis reported in 





Prevention of the postoperative deep vein thrombosis was thought 
to play as important a role as the diagnosis by special means. 
The final outcome . of treatment, cannot always be predicted. 
Fifty four patients undergoing a major elective surgical procedure 
were given prophylactic low dose subcutaneous heparin in an 
attenipt to prevent or decrease the incidence postoperative venous 
thrombosis. 
The patients were allocated to a treated or control group on the 
basis of a computerised random allocation. Patients in the 
treatment group received subcutaneous heparin, 5000 units 
2 hours preoperatively and 8 hourly after this for the first 6 
postoperative days i.e. a total of 7 days treatment. If, at the 
end of the 6th postoperative day, the p a tient was still confined 
to bed due to any condition, heparin was continued in the same 
dosage until the patient was fully mobile. The inje c tion was 
given, using a 26 gauge needle into the subcutaneous tissue of 
the w.1terior abdominal wall. A fold of skin was raised and the 
needle inserted at right angles to the skin. After injection, 
the needle was withdrawn at the same angle. Other sites 
such as arms and thighs were not used for injection. One 
sheet of the proforma was provided on which administration 
of the calcium heparin by the nursing staff could be recorded. 
This was of vital importance to the trial as evidence that the 
drug had been given. 





4. Clinical Diagnosis 




Using radioactive fibrinogen and Doppler ultrasound for 
screening and venography in selected cases to confirm the 
diagnosis the results have shown that deep vein thrombosis 
is more common than previously suspected, Thrombosis 
appears to occur more commonly in the elderly patient, 
in the obese, in those undergoing major operations, in 
patients with varicose veins or malignancy, and especially 
in those with a previous history of venous thrombosis and 
pulmonary embolism. Many thrombi start to form while 
the patients are on the operating table and most of the 
remainder develop within the next 48 hours to 72 hours. 
Patients particularly at risk require protection throughout 
this danger period. That is as long as their activities 
are restricted. Method which attempts to provide this, 
must be simple and capable of being used on a large scale. 
2. Results of Low Dose Heparin Trial 
Five patients out of 54 who received low dose calcium heparin 
developed deep vein thrombosis postope ratively diagnosed on 
sc reernng with radioactive fibrinogen and Doppler ultrasound. 
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The i11ciclence of postoperative deep vein thrombosis m the 
prophylac tically treated group was 9% as compared to the 
incidence m the control group of 51%. 
This reduction is statistically significant (P ( 0. 0005 ). 
A further 7 patients had equivocal results and were excluded. 
Of these 7 patients 
3 were positive at 1 point in the calf for 1 day only. 
2 patients were positive preopera tively and over 
the subsequent 2 days became negative. 
- 1 patient stopped heparin on the 3rd day because 
of an allergic reaction and 
1 patient stopped heparin following excessive 
bleeding post-splenectomy for myelofibrosis. 
Within two days she developed a deep vein 
thrombosis with multiple pulmonary emboli, 
was then fully heparinised with no further 
episodes of pulmonary emboli and no further 
bleeding diathe ses. 
3. Factors Possibly predisposing deep vein thrombosis. 
The Patiemt 
- Past History 
- Present History 
- Operation 
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3. Factor s 
I. The Patient 
1. Age distribution of patients developing postoperative deep 
vein thrombosis in the heparin prophylactically treated group 
was in; 
Age group 51-60 years 1 out of 13 positive 
Age group 61-70 years 2 out of 12 positive 
Age group 71-80 years 1 out of 6 positive 
Age group 81-90 years 1 out of 3 positive 
Comparison of age distribution as a percentage of positive 
control and heparin treated group is shown in Figure 19 
In all age groups there was a significant reduction in the 
incidence. 
2. Sex 
Of the 5 positives, 
3/28 were males 
and 2/26 were females 
3. Obesity 
a. Severely obese 
Mildly obese 
Normal 
1 of 5 positive 
1 of 4 
3 of 45 
Obesity did not therefore appear to be an inc reased risk m 
the treated group but numbers are small. 
4. Blood Group 
Patients developing postoperative deep vein thrombosis m 
Blood group A 
Blood group B 
2/ 16 positive 
o/ 4 positive 
FIGURE 19 AGE DISTRIBUTION OF PATIENTS 
DEVELOPING POST.OPERATIVE DEEP VEIN 
THROMBOSIS IN CONTROL AND HEPARIN 
PROPHYLACTICALLY TREATED GROUP. 
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Blood Group 0 
Blood Group AB 
Blood Group Rh positive 




5 / 3 7 po s i ti v e 
0 / 3 positive 
Rh Positive appears to be at an increased risk. 
II. Past History 
1. Previous Myocardial Infarction 
One positive out of a total of 3 patients who had a previous 
myocardial infarction. 
2. Previous Deep Vein Thrombosis 
No patients positive out of 2. 
3. Previous Pulmonary Emboli 
One positive out of a total of 4 patients. 
4. Previous Fracture of long bone o f lower limb 
No patients were positive out of a total of 3. 
III. Present History 
1. Chronic Bronchitis 
One patient positive out of 10. 
2. The Pill 
No patients positive out of 2. 
3. Varicose Veins 
One patient with bilateral varicose veins was positive out of a 
total of 5. 
4. Varicose Ulcer 
In one patient who was negative. 
5. Healed Varicose Ulcer 
One patient out of 2 was positive. This was the same patient who had 
the bilateral varicose veins. 
6. Days in Hospital Preoperatively 
Did not have any influence on the incidence. Two positive patients 
were in hospital one day preoperatively, two patients for 2 to 5 days 
and one patient for 10 to 20 days respectively. 
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IV Ope ra lion 
1. Duration of the Operation 
Two positive had operations lasting i to one hour. Three 
positive had operations lasting one to two hours i.e. 2 / 18 
were positive and 3/27 were positive r e spectively. 
Therefore duration of ope ration did not seem to have any 
importance. 
2. Type of Operation 
All 5 who were positive had abdominal operations, 2 were 
cholecystectomies, 2 were colonic re sections for carcinoma 
and one was a gastrostomy for acute gastric erosions. 
Thus 5 cases out of the total of 46 abdominal operations were 
positive . 
3. Operative Blood Loss 
In 9 patients in whom it was greater than 3 pints, none were 
positive. 
4. Operative Pathology 
Inflammation - 3 /21 patients were positive. 
Operable carcinoma - 2 / 6 patients positive. 
Inoperable carc inoma - 0/7 patients w e re positive. 
It would thus appear that the inoperable carcinoma group which 
showed a high control incidence of postoperative deep vein 
thrombosis were adequately protected by prophylactic heparin. 
5. Postoperative Complications 
Only one patient developed a urinary tract infection ( 1 /5 positive). 
Mr H. H. a European mal e aged 63 years developed a postoperative 
deep vein thrombosis on the first day . On the second 
postoperative day he h a d a n acute myocardial infarction, 
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developed congestive cardiac failure and then a cerebral embolic 
episode with diplopia. This resolved over the next 48 hours. 
On the 7th postoperative day he had a further episode of chest 
pain with extension of his myocardial infarction shown on 
electrocardiography. He developed ventricular fibrillation 
and despite all res us citation died. Unfortunately, postmortem 
was refused. 
4. Clinical diagnosis of deep vein thrombosis 
In none of the 5 patients were there any signs of deep vein 
thrombosis, but one patient developed pain in the right calf 
which was the site of the venous thrombosis shown by 
radioactive fibrinogen. 
5. Diagnosis by Radioactive Fibrinogen and Doppler Ultrasound 
All 5 patients developed calf venous thrombosis. 
The onset in three was within the first 24 to 72 hours 
postoperatively. Two cases had bilateral venous thrombosis, 
the remaining three cases were unilateral on the right side. 
In no case was the re extension to the popliteal fos sa nor was 
there ilia-femoral venous thrombosis. 
No cases developed pulmonary emboli on clinical or 
radiological examination. 
6. Treatment 
In all five cases the deep vein thrombosis was treated 
symptomatically cons is ting of elevation of the foot of the bed 
and elastic stockings. 
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7. Complications In this prophylactically treated series: 
a. Bleeding 
There was no increased objective evidence of interoperative 
bleeding in the treated group. In one patient following a 
splenectomy for myelofibro sis, with a thrombocytopaenia 
there was postoperative bleeding from the splenic bed on the 
third posto-perative day. Subcutaneous heparin was discontinued 
and the patient then developed a deep vein thrombosis with 
multiple pulmonary emboli. She was anticoagulated with a full 
dose heparin schedule with no further bleeding problems nor 
further pulmonary emboli. 
b. Wound Haematoma 
In the treated group no patients developed wound haematoma. 
c. Haematoma at Heparin Injection Site 
This occurred in .. one patient and was found to be due to an 
incorrectly administered injection using a thick needle into 
the biceps muscle. 
d. Allergy 
This occurred in one patient and was probably due to the 
alcohol swab to which the patient was shown to be allergic. 
e. Pain and Discomfort 
Provided the injection was correctly administered as 
according to the instruction sheet, no patients complained 
of pain or discomfort. 
In 20 patients in whom random clotting times were done, it was 
found that these were not prolonged. 
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c. DISCUSSION 
Pr evC'ntion 
Most prophyla ctic m ea sures are d e signed to antagonise the 
more likely c aus es of thrombosis included in Virchows Triad 
of stas is in the deep ve ins, injury to the intima and changes in 
blood coaguabi1ity ( 113). The physical methods such as leg 
exercises, active compression of the calf by pneumatic leggings 
and electrical stimulation of th e calf during operation have not 
provided sufficiently clear benefit to lead to their general 
use (6,120,123,128) . 
Drugs 
Many a ttempts have been made to prevent venous thrombosis 
by drugs . Anticoagulants hav e been used with variable success 
and are moderately effective in pr event ing pulmonary embolism 
if given under strict laborato r y control. Anticoagulation before 
surgery inc reases the risk of bleeding at operation ( 11, 186). 
Although infusion of dextran, reduces the incidence of thrombosis 
it seems not to affe ct that of pulmonary embolism. Moreover, 
dextran has a number of disadvantages (23, 106, 187). 
Aspirin and dipy ridamole have been tried because they reduce 
platel e t adhesiveness and aggregation. Both have , however, 
b een shown to be ineffective (162,186). 
Hydroxychloroquine s ulphate also r e duces platelet aggregation 
and has been r e ported to prevent th rombosis, however it 
requires further trials (159). 
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Low Dos<· Subcutaneous Heparin 1n the Prevention of Postoperative 
Deep Ve in Thrombosis 
1. Historical 
Sharnoff and his associates began this work 10 years ago, and 
they claimed in 1970 that low dose subcutaneous heparin prevented 
fatal thromboembolism ( 140). 
2. Mechanism of action 
Heparin impedes normal blood coagulation by potentiating the 
action of natural inhibitors to activate factor-X {anti-factor 
Xa) and thrombin (anti-thrombin 111). (135,141). 
Cascade mechanism for blood coagulation is shown in 
Figure 20 (188). 
V e ry low levels of heparin affect these inhibitors and high 
levels render blood incoagulable probably by completely 
blocking the autocatalytic action of factor Xa and the thrombin 
which it generates. A low plasma level of heparin greatly 
augments the effect of antifactor Xa. In the presence of 
0. 1 units of heparin/ml. plasma, antifactor Xa is increased 
to 190% of the amount pre sent in normal plasma ( 137). 
In investigating the plasma levels of heparin when administered 
intravenously and subcutaneously, it was found that 
subcutaneous heparin maintained a low but effective and constant 
l e vel of plasma heparin when compared with the wide fluctuation 
obtained by 6 hourly intravenous administration of 10,000 units. 
Th e steady low level of heparin in plasma resulted from tre 
slow releas e of heparin from 5, 000 and 10, 000 units given 
subcutaneously. 
FIGURE 20. A MODIFIED CASCADE MECHANISM 
FOR BLOOD COAGULATION 
After Williams ( 188) 
PL = Phospholipid 
Ca = Calcium 
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When giving intravenously, heparin disappeared from the plasma 
in 4 to 6 hours as judged by the calcium thrombin clotting-time 
although it was likely that there remained some potentiating 
effect of antifactor Xa {137). The high heparin level which 
followed intravenous injection could lead to serious haemostatic 
problems if surgery were carried out immediately. 
It was found that the dose regime of 5,000 units of subcutaneous 
heparin given 1 hour before operation is used by Kakkar ( 131) 
and Gordon-Smith (3) produced, during surgery levels similar 
to those resulting from 10,000 units given subcutaneously 8 to 
10 hours before the ope ration as used by Sharnoff (140). 
In summary the mechanism of action of low dose subcutaneous 
heparin is to increase the quantity of two naturally occurring 
inhibitors of coagulation i.e. antifactor Xa and antithrombin 111 
(135,141) and to reduce platelet adhesiveness {136). 
3. Clinical Studies of low dose subcutaneous heparin 1n 
prevention of deep vein thrombosis 
The ability of subcutaneous low dose heparin to preyent 
postoperative deep vein thrombosis has been assessed in a 
number of controlled trials in which radioactive 1
125 
fibrinogen 
test was used to detect the thrombosis. (1, 3, 5,131,133). 
Labelled fibrinogen was given intravenously and subsequent 
persistent concentration of the isotope in the tissues of the 
calf or lower thigh correlated weli with the demonstration of 
deep vein thrombosis by phlebography . Table V shows 
the results of 5 recent trials in patients who underwent surgery. 
In all the incidence of positive tests indicating deep vein thrombosis 
was much lower than in the controls. In the trial of Williams (5) 
the difference was somewhat obscured by the high incidence 
of positive tests after prostatectomy in both treated and control 
groups. 
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However in the trial by Gordon-Smith (3), no evidence of thrombosis 
was detected in the 6 treated patients who had a retropubic 
pro stetec tomy . 
In addition the total incidence of positive tests in patients 
treated for only one day after operation did not differ 
significantly from that in patients treated for 5 days (3). 
However, in the patients who had malignant disease, the 
incidence of positive tests was reduced only by the longer 
period of treatment ( 3). 
The largest and most recently published trial by Nicolaides {133) 
has provided the first clear link between the incidence of 
positive fibrinogen tests and that of thrombi extending 
dangerously into the proximal veins. Such a thrombus was 
found in 9 patients in the control group and none in the heparin 
treated group, a highly significant difference. None of 
the patients in the trial developed signs of pulmonary 
embolism, perhaps because the 9 patients with extending 
thrombi were promptly treated with anticoagulants. 
In another series (1) relatively few positive tests of deep vern 
thrombosis were found in a series of 133 patients considered 
to be at high risk for postoperative thrombosis, all of whom 
received Low dose heparin. This was similar whether the 
patients had benign or malignant disease. However, positive 
tt>sts were seen in 40% of 50 patients having operations for 
fractured neck of femur (1). The failure of low dose heparin 
to protect patients with such fractures or with cardiac infarction 
1s explained by the fact that activation of the factor Xa follows 
tissue damage and once this has occurred, higher doses of 
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heparin are requir ed to neutralis e it (
141). 
4. Reported Complications 
No side effects were reported 1n two o
f these studies by 
Kakkar (13) and Williams (5). Woun
d haematomas developed 
in 4 per cent of treated patients in Go
rdon-Smith's study (3) 
but in a largest trial so far by Nicolai
des, they occurred with 
equal frequency in the control and trea
ted patients (133). 
Troubl e some bleeding was repo r ted in
 two trials, the incidence 
being 4 out of 345 patients (1, 131). I
n all 4 patients there were 
other factors which may have been pa
rtly responsible. 
Bruising at the injection site did not g
ive rise to many complaints, 
even when dose.s of 7, 500 units were g
iven 12 hourly ( 142). 
In some trials (1, 131) calcium heparin
 was used because it 
was supposed to cause less local blee
ding, but in other trials 
( 3, 131) sodium heparin caused haema
tomas at the injection 
sites in only 6 out of 222 patients, and
 in 4 of these the injection 
was given incorrectly. 
This treatment is safe, cheap and sim
ple to administer and the 
basic National Health Service co st of 
5 ml bottle containing 
5000 international units of heparin per
 ml is less than 25 pence. 
A 7 day perioperative course would th
us cost 75 to 90 pence 




Prophylactic subcutaneous heparin has reduced the incidence of 
postoperative deep vein thrombosis in patients undergoing major 
elective general surgical procedures 
from 51% m the control group, to 9% m the treated group 
at G :rnote Schuur Hospital (P( O. 0005) 
Furthermore, in those patients who did develop postoperative 
deep vein thrombosis, this was localised to the calf and did not 
extend proximally. There were no cases of popliteal or 
ilia-femoral venous thrombosis or pulmonary emboli. 
Low dos e subcutaneous heparin is therefore an effective, safe 
simple to administer and low cost method of preventing postoperative 
deep vein thrombosis with its associate morbidity both in the 
acute and chronic phase and its mortality. 
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l. PREVENTION 





1. . HIGH DO SE TA VAN - SP 54 
Twelve patients were included in the trial using high dose 
Tavan SP-54. One hundred mg. was given two hours 
preoperatively followed by 100 mg 6 hourly. Of the 12 
patients, 6 were positive and 6 were negative. Of the 6 
patients who developed deep vein thrombosis, 3 developed 
the complication of bleeding which resulted in wound haemato
ma, 
and of the 6 negative patients, 4 developed bleeding. 
Bleeding was thus a complication in 7 of the 12 cases. 
Three patients were returned to theatre for evacuation of 
wound ha ematomas . 
tri a l was stopped . 
It was felt unethical to continue and the 
2. LOW DOSE TA VAN SP-54 
Sixty one patients were included in the low dose trial. 
However 13 cases were ei ther discharged before the third 
postoperative day or the fibrinogen count had disappeared, an
d 
were thus excluded from the trial. 
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Of the 48 remaining patients, 7 were positive according to the 
criteria and thus were diagnosed as having developed postoperative 
deep vein thrombosis whilst on treatment giving an incidence 
of 15% (P ( . 005). One patient died due to septicaemia 
and at postmortem it was confirmed that there was venous 
thrombosis in the right femoral vein, the posterior tibial vein 
with the presence of small pulmonary emboli. 
Forty one patients {85%) were negative and did not develop a 
deep vein thrombosis postoperatively whilst on Tavan SP-54. 
However, 12 of the 41 negative patients had an isolated count 
in the calf which lasted for one day only (25%). By Kakkar's 
criteria (26) these cases were regarded as not having 
developed postoperative deep vein thrombosis. 
The onset of the deep vein thrombosis was within the first 
postoperative day in 4 patients and within the second post 
operative day in 3. 
In only one of the 7 patients was there extension of the thrombosis 
over the next three days and it subsequently underwent 
spontaneous thrombolysis. 
On clinical and special investigations there was 
no evidence of pulmonary emboli except in the one fatal case 
previously referred to. 
Complications 
Bleeding resulting in wound haematomas occurred 1n two 
patients, one from each group. 
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b . DISCUSSION 
1. Chemistry 
Sodium Pentosan Polysulphate is the generic chemical name 
for a polysaccharide ester which is semi-synthetically prepared 
and is a sulphated polyanion. 
a polymer chain. (196). 
2. Spectrum of Action 
The basic units are pentoses in 
Shown experimentally and clinically 
There have been numerous publications of the action of Tavan 
SP-54 (157, 189, 190, 191, 194) It appears to activate the 
fibrinolytic system (189) and cause thrombolysis (190). 
It accelerates intrvascular lipolysis (157) with release of 
clearing factors and mobilisation of lipoid deposits in the tissue 
(191, 192). It has an anti-sludge effect with the correction of 
rouleaux formation in the micro -circulation ( 19 3). It inhibits 
hyaluronidase activity (194) and appears to have anti-inflammatory 
and anti-oedema effects (195). 
3. Indications 
The manfac turer s claim that the drug can be used in degenerative 
arterial disease, thrombosis and embolism and hyperlipidaemia ( 196). 
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4. Postoperative Prevention of D ee p Vein Thrombosis 
Kraft ( 158) reported the use of Ta van SP 54 in the pr evention of 
postoperative deep vein thrombosis. The drug was given to 
3, 522 cases, the majority undergoing abdominal operations . 
Results of these cases showed that only 3 patients ( ( 0.1%) 
died of pulmonary embolism. ( Tabl e XVIII). There were 
no side effects nor contraindications to its use, that the 
drug had no anticoagulant action and probably activated the 
fibrinolytic system. 
Although the results show a significant reduction in the 
postoperative complications (See Table XVIII), the criticism 
of this trial is that the diagnosis of deep vein thrombosis 
was made purely on clinical grounds which would approximate 
the local incidence diagnosed clinically. No mention was 
made either of the method of diagnosis of pulmonary 
embolism and whether the patients r epo rted ha v ing died of 
pulmonary emboli had confirmatory post mortem or not. 
TABLE XVIII INCIDENCE OF POSTOPERATIVE DEE P VEIN 
THROMBOSIS, PULMONARY EMBOLI AND DEATHS IN CONTROL 
AND TA VAN SP-54 TREATED PATIENTS. After Kraft (158) 
No Prophylaxis Prophylaxis 
1950-1957 19 58 -19 62 
13,600 3 , 522 cases 
1. Postoperative deep vein + 
thrombosis 3. 15 - o. 58% (1% 
2. Pulmonary emboli 1. 5 ~ 2.9% ( 0. 2% 
3. Death due to pulmonary 
o. 53 ~ e mboli •15% 0. 08% 
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haemotological investigations for its control of dosag e. 
Tavan SP 54 in the low dose of 50 mgm 2 hours preoperatively 
and then 50 mgm 12 hourly by injection caused significant 
reduction in the incidence of postoperative deep vein thrombosis 
from 
51% in the control to 
15% in the treated group (P < . 005) 
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As this was the only clinically reported work on Ta van SP-54 
in the prevention of deep vein thrombosis , it was decided to 
undertake a controlled trial to test its efficacy. 
This study shows a reduction in the inc id enc e of postoperative 
deep vein thrombosis from 51% in the control group to ' 15% in the 
in the treated group using low dose Tavan SP-54. In one case 
deep vein thrombosis and multiple pulmonary emboli were shown 
which were not the cause of death. In only one case was there 
ex tension of the thrombosis and all the remaining cases underwent 
thrombolysis. The only complication recorded was in two cases 
who developed wound haematoma which spontaneously resolved 
over a subsequent week. High dose Ta van SP 54 however did 
not prevent postoperative deep vein thrombosis and caused 
bleeding. Why there should be this difference in the results 
with the two doses cannot be explained. 
c. CONCLUSION 
The pharmacological action of Tavan SP-54 has not been adequately 
elucidated in the literature, Past reports on its effects in the 
postoperative pr evention in deep vein thrombosis are outdated ( 158) 
due to the modern methods of screening and diagnosis. 
It h a s been s hown that there is a place for Tavan SP 54 m the 
prevention of postoperative deep vein thrombosis. However, 
Tavan SP-54 used in the high dose of 100 mgs 2 hours preoperatively 
and 100 mgs 6 hourly postoperatively carried considerable morbidity 
due to bleeding and did not prevent d ee p vein thrombosis. 
If this drug is to be used in the treatment of postoperative deep 
vein thrombosis it must obviously not be used too early 
postope r a tiv e ly in higher doses or must b e used in a reduced 
dos age. Th e r eason for this is that th ere are n o reliable 
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SECTION C 
FINAL CONCLUSION AND POSSIBLE FUTURE RESEARCH 
The INCIDENCE of deep vein thrombosis occurring postoperatively 
in the General Surgery wards at Groote Schuur Hospital in an 
analysis of 130 cases was 51%. The diagnosis of deep vein 
thrombosis was made by Clinical examination, Radioactive 
fibrinogen scanning, Doppler ultrasound and Venography in 
selecte d cases. 
In the ANALYSIS OF FACTORS which may have contributed 
to this high incidence, it was shown that deep vein thrombosis 
occurs at all age groups, but there was a significant increase 
in the over 40 year age group. There was no sex difference 
and the complication occurred equally in European and Non-
European patients. The Non-European patients were 
predominantly Cape Coloured, however in a few cases of 
Bantu and Indian patients studied . the incidence was 
approximately the same . Obesity appeared to play a 
significant role - the severely obese patients as defined by 
height and weight for age, had a much higher incidence of 
deep vein thrombosis. Blood group did not appear to play 
any significant role but numbers too small. Past history 
of myocardial infarction, fractures of the long bones of 
the lower limb, pulmonary embolus or deep vein thrombosis 
did not play a significant role. However, there were too 
few patients who had a previous pulmonary embolus or deep 
vein thrombosis diagnosed clinically. 
could be made in this regard. 
No further comment 
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Patients with varicose veins were more prone to the d e velopment 
of deep vein thrombosis on the side of the varicose veins as 
well as those patients demonstrating a varicose ulcer. 
This was presumably related to the past deep vein thrombosis 
underlying the aetiology of the varicose ulcer. 
Duration of stay in hospital preoperatively did not appear to be 
a significant factor, although it seemed likely that the longer 
the operation the more prone the patient should be to the 
development of deep vein thrombos i s but our figures did not 
confirm this. 
In the type of operation performed there was an equal 
distribution among all types of operations grouped into head 
and neck, breast, vascular, exploratory laparotomy and 
hernia. A slight increase was shown in those patients 
undergoing stomach, duod e nal and extrahepatic biliary 
operations, however, this was shown to be not statistically 
significant. 
Incid.ence, according to operative blood loss exceeding more 
than 3 pints did not play a role, The operative pathology 
was evenly distributed amongst the sub-groaps of congenital, 
traumatic, inflammatory, however the irresectable 
carcinoma in which a palliative procedure was performed, 
showed a significant increased risk. 
Postoperative complications as well as postoperative days 1n 
hospital were not related to an increased risk. 
In conclusion the only high risk cases found in this study have 
bL~en palie nts in Lhe age group of over 40 years, who were 
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seve r e ly obese, with varicose veins and healed varicose ulcer 
with a n irresectable carcinoma undergoing an elective major 
operation under a general anaesthetic. 
Factors which were not of significance were race, duration of 
preoperative stay, type of operation, length of operation, 
postope rative hospitalisation, operative bloodloss and 
postoperative complications. One could not , how ever 
exclude the patients who had had a past deep vein thrombosis 
as not being at increased risk as well as patients who had 
sustained fractures of their lower limbs as the series did not 
include a sufficient number of these patients. 
TECHNIQUES OF DIAGNOSIS 
The results showed that the classical clinical signs for the 
diagnosis of deep vein thrombosis were absent in the majority 
of cases, and only 7. 5% of the total number of patients who 
developed a postoperative deep vein thrombosis would have 
been diagnosed on clinical grounds alone. Furthermore 
clinical diagnosis was erroneous in one patient. The 
symptom of pain in the calf, often only obtained by careful 
questioning, was far more r e liable than the clinical signs 
and accounted for 26% of the cases diagnosed clinically. 
Radioactive fibrinogen t e chnique was found to be a ,safe reliable 
method of diagnosis, but required trained technical staff 
and the duration of the investigation was 15 to 20 minutes per 
patient per day. It was reliable in 100% of our cases, 
and its sensitivity was superior to that of venography in 
that small thrombi in the calf muscles were demonstrated 
by fihrinogen but were not shown up by venography. 
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In the duration of radioactive fibrinogen counting there were 
initial problems at the beginning of the trial due to the poor 
quality of fibrinogen. However, in the latter part of the trial, 
counts were being obtained up to two to three weeks postoperatively. 
If the patient presented with a deep vein thrombosis which was 
labelled by radioactive fibrinogen, and over the subsequent 
few days the counts disappeared, it was possible that the 
patients' thrombus had embolised to the lung. However, in 
no patients was there a correlation found between the 
disappearance of the thrombus and the development of the 
pulmonary embolus shown clinically radiologically, electro -
graphically or by enzyme increases. The loss of radioactive 
counting was thought due either to the metabolism of the 
fibrinogen or to loss of radioactivity. The only complications 
encountered by the radioactive fibrinogen procedure was an 
iodine allergic reaction in one patient. The serum came 
from a select group of donors, Australian antigen negative, 
and although the follow up was too short there have been no 
cases with serum hepatitis attributable to the radioactive 
fibrinogen. In all cases the thyroid was blocked by sodium 
iodide. It must be pointed out, however, that in 5 patients 
not in this series who presented with pleuritic chest pain, 
no clinical signs, normal ECG and x-ray chest, only on lung 
scan was there a wedge shaped infarct compatible with a 
pulmonary embolus. Therefore, in the future to assess 
the true incidence of postoperative pulmonary emboli, 
routine lung scans should be performed in addition to ECG 
and radiological investigations. 
Radioactive fibrinogen test was found to be an extremely 
useful screening test for the diagnosis of calf and lower thigh 
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veno us thromboses i.e. from 10 ems below the inguinal ligament 
to the ankle joint, but was unreliable for the upper thigh . 
Doppler ultrasound used as a screening procedure in combination 
with radioactive fibrinogen was found to be a reliable test for 
the diagnosis of popliteal, femoral and iliac venous thromboses. 
It was unreliable for the diagnosis of small calf venous thrombosis 
where there was no disturbanc e of venous flow . In the patients 
who were thought to have a pulmonary embolus with no clinical 
evidence of lower limb deep vein thrombosis, used as an isolated 
test, the findings at Groote Schuur Hospital in 22 of these 
patients who were not included in the trial, it was not very 
reliable. 
The Doppler ultrasound was reliable in 80% of patients shown on 
venography to have venous occlusion, and in 20% of patients 
there was a false negative result. This was due to either a 
non-occlusive venous thrombosis or the development of 
adequate collateral circulation. Furthermore, using the 
Doppler ultrasound on the principle of 11 all or none 11 in regard 
to a sound being present or absent, non-occlusive venous 
thrombosis can be missed. 
Doppler ultrasound therefore was found to be a useful 
screening method provided it was used with radioactive 
fibrinogen and provided the screening was carried out 
preoperatively for a baseline and daily or every second day 
to detect a change in the recording. 
Venography was used as a definitiv e diagnostic method. 
It carried a smali risk of complications and thus should not 
be used as a routine method in the diagnosis of deep vein 
thrombosis postoperatively. It is usually only carried out 
once and was thus useless as a screening procedure . 
• 
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Furthermore, the venous thrombosis could occur several 
days or weeks after the venography was performed and 
therefore be missed. Indications for its use should be 
reserved for those patients who present as diagnostic problems, 
those undergoing thrombectomy or thrombolytic therapy 
using streptokinase or urokinase. 
ONSET OF VENOUS THROMBOSIS 
Results show that the deep vein thrombosis began to form 
while the patient was still on the operating table and over 75% 
were present within the first 48 to 72 hours. This fact is 
of the utmost importance in using measures to prevent venous 
thrombosis. 
Deep vein thrombosis was bilateral in two thirds of the 
patients and unilateral in one third, the right side being 
twice as commonly involved as the left side. The site of 
the venous thrombosis in two fifths of the patients was localised 
to the calf and in three fifths the I?opiteal and ilio -femoral veins 
were involved. The popliteal vein was involved in 33% and 
the thigh alone or in combination in 24%. 
This presents a considerably greater incidence of involvement 
of the popliteal and ilio -femoral venous segments than 
previously reported in clinical studies using radioactive 
fibrinogen alone (2 6), but confirms the pathological findings 
at post-mortem (88 . 89). 
Calf venous thrombosis in the acute phase is only important 
if it extends into the popliteal and ilio -femoral veins, when 
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50% of patients may have pulmonary emboli , which is the 
pres e nting s y mptom in 50%, and 30% may die as a di rect 
result of their pulmonary emboli ( 173). It is tnus important 
to have a daily screening programme to detect the calf 
venous thromboses which extend and to watch the natural 
progression of the calf vein thrombosis as well as to diagnose 
early on the popliteal and ilio -femoral venous thrombosis 
so that treatment can be urgently carried out. 
THE NATURAL HISTORY 
The natural history of venous thrombosis is said to be to 
undergo spontaneous thrombolysis in the majority of cases. 
A small percentage recanalise and give rise to incompetent 
perforators and the post-phleb itic syndrome. A long term 
follow up of the cases in this series have not been carried out. 
It appeared to be of the utmost importance to follow these 
patients up long term and to try and define the natural history 
of postoperative deep vein thrombosis. The questions to be 
answered are whether these patients were more liable to further 
attacks of v enous thrombosis both spontaneously or following 
trauma or operation. Furthermore, what percentage would 
develop the post-phlebitic syndrome. Dodd and Cockett ( 12) 
state that over 75% would develop the post-phlebitic syndrome. 
If this is so, the length of time required for the development of 
venous ulcers should be determined and what prevention could 
be used in the early and the late stage. At present at Groote 
Schuur Hospital heparin is the only anticoagulant used initially, 
if the v e nous thrombosis extended into the popliteal vein or 
involved the ilia-femoral vein. Howe ver, the question arises 
whether perhaps anticoagulants should be given to patients with 
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thrombi in the calf veins to prevent the thrombotic extension 
and thus prevent the early complication of pulmonary emboli 
and the late sequelae of the post-phlebitic limb. 
The results also show that a number of the venous thromboses 
were bilateral, extensive, non-consecutive, multifocal and 
non-occlusive. A full assessment of the venous system of both 
lower limbs should always be made. 
NEUROSURGICAL 
In the neurosurgical unit an incidence of 43% of postoperative 
venous thrombosis was detected. Those underg6ing spinal 
operations showed nearly twice the incidence of those undergoing 
cranial operations. In both groups the only possible differences 
were that the patient undergoing spinal operations were turned 
passively two hourly by attending nursing staff. Stasis might 
therefore have played a very important role in this group. 
It would appear in this group the role of prophylaxis should be 
extensively investigated. 
In the OPHTHALMOLOGY AND OTOLAR YNGOLOGY wards 
the combined incidence was less than 10%. This group of 
patients underwent an operation under general anaesthetic, 
lasting more than half an hour. Age distribution was compatible 
with the control group and the major difference was the minimal 
interoperative tissue trauma especially in the ophthalmology 
patients undergoing lens extraction. It was interesting to 
note that both the patients who developed deep vein thrombosis 
were obese, elderly and one had bilateral varicose veins. 
• 
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Interoperative tissue trauma might thu3 play an important 
role in the production of the postoperative hypercoaguable 
state. In the ophthalmology patients, a study should be 
carried out to determine the incidence of patients developing 
deep vein thrombosis following a lens extraction under local 
anaesthetic. If the incidence is lower than the present 
incidence, all cases at high risk should undergo their 
operations under local anaesthetic. 
PROPHYLAXIS 
In the prevention of deep vein thrombosis mention has been 
made that all factors contributing to Virchow' s triad should 
be taken into consideration i.e. stasis, intimal damage of 
veins and hypercoaguability. 
The results, using low dose heparin show a decline in 
incidence of postoperative deep vein thrombosis from 51% 
to 9 % which is statistically significant. As only 5 patients 
developed postoperative deep vein thrombosis on heparin, 
it was difficult to reach any definite conclusion concerning 
possible high risk factors in these patients . 
Tavan SP-54 also reduced the postoperative incidence of deep 
vein thrombosis from 51% to 15% but there was the associated 
complication of bleeding. The development of deep vein 
thrombosis in the high dose trial has not been adequately 
explained. 
In the routine prophylaxis of postoperative deep vein thrombosis 
low dose heparin would appear to be tb e drug of choice. 
• 
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The general surgical unit at Groote Schuur Hospital where surgery 
on more than 350 patients is perform ed und e r general anaesthetic 
per month , it would be a costly proc edure to screen every patient 
daily preoperatively and then postoperatively with radioactive 
fibrinogen and Doppler ultrasound. Two full time technicians 
using two sets of instruments would be required. The monthly 
cost of salaries and equipment would be approximately RlOOO 
per month with an initial outlay of RSOOO for the equipment. 
To reach a compromise it would appear better to screen 
those high risk patients liable to develop deep vein thrombosis 
postoperatively such as the very obese patients with varicose 
veins or a varicose ulcer, past history of deep vein thrombosis 
or pulmonary emboli and with possible operative pathology of 
carcinoma. 
Perhaps an even more practical approach to the problem would 
be that every patient undergoing a general anaesthetic procedure 
lasting more than half an hour should be routinely given low 
dose heparin - 5000 units two hours preoperatively or with 
the premedication and then 8 hourly postoperatively until the 
patient was fully mobilised. 
It would appear that an effective low cost , practical method 
of the prevention of postoperative deep vein thrombosis has 
been found in heparin. It would thus be more logical that 
if such a n1.cthod is available, it is far easier and more 
practical to prevent the deep vein thrombosis than to try and 
diagnose and then have to treat more than half of the patients 
with full anticoagulation. 
The possible complications of deep vein thrombosis, 
pulmonary emboli and anticoagulation would be prevented. 
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